ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Bioelectronics Corp (PK)

Bioelectronics Corp (PK) (BIEL)

0.0001
-0.0001
( -50.00% )
Updated: 11:57:25

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.0001
Bid
0.0001
Ask
0.0002
Volume
5,806,287
0.0001 Day's Range 0.00015
0.0001 52 Week Range 0.0006
Market Cap
Previous Close
0.0002
Open
0.0001
Last Trade Time
11:57:25
Financial Volume
$ 595
VWAP
0.000103
Average Volume (3m)
17,085,199
Shares Outstanding
24,710,000,000
Dividend Yield
-
PE Ratio
-
Earnings Per Share (EPS)
-
Revenue
715k
Net Profit
-723k

About Bioelectronics Corp (PK)

Sector
Electromedical Apparatus
Industry
Electromedical Apparatus
Headquarters
Frederick, Maryland, USA
Founded
1970
Bioelectronics Corp (PK) is listed in the Electromedical Apparatus sector of the OTCMarkets with ticker BIEL. The last closing price for Bioelectronics (PK) was $0. Over the last year, Bioelectronics (PK) shares have traded in a share price range of $ 0.0001 to $ 0.0006.

Bioelectronics (PK) currently has 24,710,000,000 shares outstanding.

BIEL Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.00010.00020.0001103104940.00014717CS
4-5.0E-5-33.33333333330.000150.00020.0001102388820.00015825CS
12-0.0002-66.66666666670.00030.00030.0001170851990.00016789CS
26-0.00025-71.42857142860.000350.00040.0001220256570.00021251CS
52-0.0004-800.00050.00060.0001169358190.00027823CS
156-0.0028-96.55172413790.00290.00380.0001207498640.0009345CS
260-0.0006-85.71428571430.00070.00880.0001330998510.00155414CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AREBAmerican Rebel Holdings Inc
$ 0.733
(143.52%)
256.9M
NXLNexalin Technologies Inc
$ 1.956
(77.82%)
35.76M
SHCRSharecare Inc
$ 1.37
(76.91%)
31.17M
SPECSpectaire Holdings Inc
$ 0.549
(61.47%)
57.79M
SRPTSarepta Therapeutics Inc New
$ 166.39
(34.73%)
8.42M
KAVLKaival Brands Innovations Group Inc
$ 1.545
(-46.17%)
3M
PBMPsyence Biomedical Ltd
$ 0.4051
(-32.48%)
2.08M
RELIReliance Global Group Inc
$ 0.458
(-24.16%)
6.9M
IPDNProfessional Diversity Network Inc
$ 0.51
(-21.04%)
2.72M
OLBOLB Group Inc
$ 2.55
(-19.56%)
25.53k
AREBAmerican Rebel Holdings Inc
$ 0.733
(143.52%)
256.91M
NVDANVIDIA Corporation
$ 130.29
(-0.37%)
255.28M
CRKNCrown Electrokinetics Corporation
$ 0.0409
(-18.20%)
122.92M
ASTIAscent Solar Technologies Inc
$ 0.1172
(8.62%)
108.4M
NKLANikola Corporation
$ 0.37685
(14.34%)
78.83M

BIEL Discussion

View Posts
ddls ddls 1 minute ago
This company has failed to produce profits in their 22 year history. They tried every trick in the book, but failed. The company is on it's last leg.
👍️0
art2426 art2426 9 minutes ago
I would sure hate to be one of those note holders that loaned money to get that stock conversion deal for their loans, the way this is going. Even the ones that got that 50% discounted stock price on those note/loan conversions must be a little concerned right now. They must have thought they had a no lose deal they made with this company and family management. Because if this continues as it is ------ what is 50% of nothing?
👍️0
edbi46 edbi46 5 hours ago
NOPAIN Act
Jan. 1, 2025

https://www.congress.gov/bill/117th-congress/house-bill/3259/text?s=2&r=1&q=%7B%22search%22%3A%22NOPAIN+ACT%22%7D

Just to highlight a few points::

(G) ACCESS TO NON-OPIOID TREATMENTS FOR PAIN.—
“(i) IN GENERAL.—

Notwithstanding any other provision of this subsection, with respect to a covered OPD service (or group of services) furnished on or after January 1, 2022, and before January 1, 2027, the Secretary shall not package, and shall make a separate payment as specified in clause (ii) for, a non-opioid treatment (as defined in clause (iii)) furnished as part of such service (or group of services).

“(ii) AMOUNT OF PAYMENT.—
The amount of the payment specified in this clause is, with respect to a non-opioid treatment that is—

“(I) a drug or biological product, the amount of payment for such drug or biological determined under section 1847A; or

II) a medical device, the amount of the hospital’s charges for the device, adjusted to cost.

“(iii) DEFINITION OF NON-OPIOID TREATMENT.
A ‘non-opioid treatment’ means—

“(I) a drug or biological product that is indicated to produce analgesia without acting upon the body’s opioid receptors; or

“(II) an implantable, reusable, or disposable medical device cleared or approved by the Administrator for Food and Drugs for the intended use of managing or treating pain;

that has demonstrated the ability to replace, reduce, or avoid opioid use or the quantity of opioids prescribed in a clinical trial or through data published in a peer-reviewed journal.”.>>>>

Ambulatory Surgical Center Payment System.—Section 1833(i)(2)(D) of the Social Security Act (42 U.S.C. 1395l(i)(2)(D)) is amended—

(1) by aligning the margins of clause (v) with the margins of clause (iv);

(2) by redesignating clause (vi) as clause (vii); and

(3) by inserting after clause (v) the following new clause:

“(vi) In the case of surgical services furnished on or after January 1, 2022, and before January 1, 2027, the payment system described in clause (i) shall provide, in a budget-neutral manner, for a separate payment for a non-opioid treatment (as defined in clause (iii) of subsection (t)(16)(G)) furnished as part of such services in the amount specified in clause (ii) of such subsection.”.

(c) Evaluation Of Therapeutic Services For Pain Management.—
1) REPORT TO CONGRESS.—

Not later than 1 year after the date of the enactment of this Act, the Secretary of Health and Human Services (in this subsection referred to as the “Secretary”), acting through the Administrator of the Centers for Medicare & Medicaid Services, shall submit to Congress a report identifying—

(A) limitations, gaps, barriers to access, or deficits in Medicare coverage or reimbursement for restorative therapies, behavioral approaches, and complementary and integrative health services that are identified in the Pain Management Best Practices Inter-Agency Task Force Report and that have demonstrated the ability to replace or reduce opioid consumption; and

(B) recommendations to address the limitations, gaps, barriers to access, or deficits identified under subparagraph (A) to improve Medicare coverage and reimbursement for such therapies, approaches, and services.>>>>

(2) PUBLIC CONSULTATION
.—In developing the report described in paragraph (1), the Secretary shall consult with relevant stakeholders as determined appropriate by the Secretary.

(3) EXCLUSIVE TREATMENT.
—Any drug, biological product, or medical device that is a non-opioid treatment (as defined in section 1833(t)(16)(G)(iii) of the Social Security Act, as added by subsection (a)) shall not be considered a therapeutic service for the purpose of the report described in paragraph (1).
____________________________________________________________
Nasdaq news:
BioElectronics Corporation Announces Utility Patent Application Filing

PUBLISHED
MAY 21, 2024 8:09AM EDT
Non-Invasive Device Addresses the Treatment of Chronic Inflammation

FREDERICK, MD - (NewMediaWire) - May 21, 2024 - BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL a developer of medical technology products, today announces the filing of a new USPTO utility patent application addressing the treatment of chronic inflammation. This patent application, numbered 18/667,971, was a collaborative effort of John Martinez, Kenneth McLeod, PhD, and Richard Staelin, PhD. It outlines methods, systems, apparatuses, and devices that modify the immune response through non-invasive stimulation of the vagal nerves. The application draws from the results of a recently completed double-blind, placebo-controlled, canine study, published in Veterinary Medicine and Science which demonstrated that Pulsed Short Wave Therapy (PSWT) Technology applied to the vagal nerves of dogs diagnosed with osteoarthritis resulted in significant reductions in systemic discomfort.

https://www.nasdaq.com/press-release/bioelectronics-corporation-announces-utility-patent-application-filing-2024-05-21
____________________________________________________________

Pulsed Electromagnetic Field Enhances Caffeic Acid Phenethyl Ester-induced Death of MCF-7 Breast Cancer Cells
https://pubmed.ncbi.nlm.nih.gov/38821617/


ORTHOALLIANS
RecoverRX!!
https://orthoalliance.com/optimal-recovery/

___________________________________________________________

A study investigating the efficacy of our FDA-cleared (human use) pulsed-shortwave-therapy (PSWT) device in initiating a systemic anti-inflammatory response to improve the functionality of canines diagnosed with osteoarthritis. 96% of the treatment group showed either increased passive range of motion, improved behavioral changes, or both compared to 4% for the placebo group. It was published today online in "Veterinary Medicine and Science." Medical professionals can contact us at info @newbie00 to request sample products.

Pulsed shortwave electromagnetic field therapy increases quality of life in canines with symptoms of osteoarthritics
Tanya Ella Sprunks, Kenneth J. McLeod, Richard Staelin
First published: 22 March 2024 https://doi.org/10.1002/vms3.1408
Sree Koneru and Jack Merrifield contributed equally to this study.

https://onlinelibrary.wiley.com/doi/10.1002/vms3.1408
_________________________________________________

News
BioElectronics’ pulsed shortwave therapy device is effective for limb pain: study says
Staff Writer February 26, 2024

https://www.nsmedicaldevices.com/news/bioelectronics-pulsed-shortwave-therapy-device/

_________________________________________________

This is just a few FACTS to help with INTELLIGENT DD and to INVEST in BIEL, which, i/we agree with this post worth a reasonable investment:
(https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172266874;; )

INTRODUCING
RecoveryRx Veterinary
Drug-Free Pain Relief Device
For Indoor and Outdoor Pets
https://rrxvet.carrd.co/

PEMF Ring is Saving a 14 Year Old Labrador
https://therapyproducts.net/pemf-ring-is-saving-a-14-year-old-labrador/

"As the sole UK and European distributor of Recovery RX Veterinary, Tanya Sprunks offers advanced long-lasting pain relief for pets using Electromagnetic Pulse Therapy. She operates several successful clinics across Devon, focusing on Veterinary Physiotherapy."
https://www.glebevets.co.uk/services/physiotherapy/

" RecoveryRx repairs and regenerates damaged cells by reducing pain and inflammation and accelerating blood flow. Whereas, TENS is only blocking pain signals and has no healing effect. The major difference between the two is that a TENS unit is a short term solution that “turns off” the pain signal but CANNOT perform the function of repairing damaged tissue like RecoveryRx. "
https://www.linkedin.com/posts/lauren-jarman-380a801a9_clinicallyproven-fdacleared-noninvasive-activity-7051200138563735553-Q9Zs

7 Well-Being Benefits of PEMF Therapy
https://www.samuelmaddockhealth.com/pemf/7-well-being-benefits-of-pemf-therapy

"Literally, there are so many benefits to a regular PEMF therapy session. Research by NASA and other bodies has found that PEMF therapy can deliver the following results:
Better circulation
Pain reduction
Improved muscle relaxation and performance
Decreased inflammation and swelling
Improved oxygenation in tissue
Enhanced cellular repair and recovery
Improved immune system
Better sleep "
https://higherdose.com/blogs/news/8-benefits-of-pemf-therapy?psafe_param=1&tw_source=google&tw_adid=634407957086&tw_campaign=18892036948&gad=1&gclid=CjwKCAjw44mlBhAQEiwAqP3eVqY1HlussPIpcLNFP0O10gqhWUrMI0VdqtspfI3FlKHqC0HkjB_OkBoCc08QAvD_BwE

BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

-------------------------------------------------------------------------------------------------

Actipatch ranked #1 in NASA Electromagnetic Pain Relief/Blocking: Feasibility Assessment !!!!!!!!

National Aeronautics and Space Administration
Lyndon B. Johnson Space Center
Houston, Texas 77058
( pages 14, 15 )........


Context/Background:

Astronauts use pharmaceuticals during spaceflight to manage acute and chronic pain, but use of analgesics will have drawbacks for exploration-class missions because the shelf life of these medications is limited, resupply will be curtailed, astronauts may develop tolerance and/or addiction to these medications, and side effects can include impairment of
cognitive abilities. Electromagnetic devices have been developed that treat pain terrestrially by affecting neuromodulation–dubbed “electroceuticals”, these devices have varied mechanisms of action that either stimulate or suppress neural activity in the central nervous system or peripheral nerves.

Objective/Purpose:

The available literature was reviewed and FDA-approved pain treatments (both pharmacological and non-pharmacological), as well as those currently under development, were assessed for their suitability for use in exploration class spaceflight missions.

Results:

An overwhelming majority of the literature focuses on the treatment of chronic rather than acute pain because it is assumed that acute pain only rarely fails to resolve and instead transitions into chronic pain when the central nervous system becomes hypersensitized. The available electromagnetic devices marketed for pain treatment have varying levels of
invasiveness, use different mechanisms of action, and have demonstrated varying efficacy when evaluated scientifically. A truly noninvasive, highly efficient device is desired for use during spaceflight. One portable, self-contained, FDA-approved device was identified that, from preliminarily assessment, best met these criteria; the device noninvasively applies pulsed
shortwave therapy (PSWT) to modify pain signals from peripheral nerves, however, the device has limited battery life and the effects are relatively non-selective in type of neural signal modified.

Ranking:

The treatment method ranked first in this review was pulsed
shortwave therapy (PSWT), a low-power RF (MHz range) transmitter operated adjacent to biological tissue at maximum output (saturation) to modulate peripheral nerve activity. ActiPatch is a very small wearable PSWT device that is FDA approved for “adjunctive treatment of musculoskeletal pain”
[Anwar-Deen 2020]. It is low cost, low power, and boasts 97% efficacy in reducing pain (85% over a 6-month period) [Staelin 2019]. The device can be secured to the body by physio tape and the area causing pain is bounded by the device’s ring. The device can be turned on and off, and the non-rechargeable battery is capable of 720 hours of operation
(one month continuous use). ActiPatch is sold OTC in local pharmacies for ~$30 [ActiPatch 2020].

Conclusions:
The information obtained in the execution of this review effort leads to 2 recommendations for forward work:

1. Tie into DoD and NIH research funding efforts to improve pain treatment: the NIH has a federal partners workgroup for their HEAL Initiative that could conceivably be joined by NASA, and the DoD CPMRP’s initial solicitation only recently completed so that program is young and potentially synergies could be identified with NASA.

2. Obtain an ActiPatch device for evaluation and determine whether it could be beneficial and adapted to spaceflight use.

https://ntrs.nasa.gov/api/citations/20205008893/downloads/2020ICA_Mullenax_report_24Sep20.pdf

___________________________________________________________

INTRODUCING
RecoveryRx Veterinary
Drug-Free Pain Relief Device
For Indoor and Outdoor Pets
https://rrxvet.carrd.co/
BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

PEMF Ring is Saving a 14 Year Old Labrador
https://therapyproducts.net/pemf-ring-is-saving-a-14-year-old-labrador/

"As the sole UK and European distributor of Recovery RX Veterinary, Tanya Sprunks offers advanced long-lasting pain relief for pets using Electromagnetic Pulse Therapy. She operates several successful clinics across Devon, focusing on Veterinary Physiotherapy."
https://www.glebevets.co.uk/services/physiotherapy/

___________________________________________________________

Skymedicalsupply
•skymedicalsupply's profile picture
Introducing the EME BACK WRAP with ActiPatch® Technology, a revolutionary pain relief solution for your back. This innovative wrap utilizes ActiPatch® technology, clinically proven to alleviate pain by regulating the activity of sensitized nerves and reducing abnormal pain signaling. With its ability to deliver 1,000 sensation-free electromagnetic pulses per second, this wrap offers effective relief for up to 720 hours.
https://investorshangout.com/post/view?id=6690577
___________________________________________________________

Welcome to the largest
health and beauty store in Europe! PromoFarma is the marketplace which groups the catalogues from more than 1.000 pharmacies and other sellers into one single website, selects the basket of products at the best price, collects the order from the selected pharmacies and delivers it wherever you want.
ActiPatch effective knee-pain relief !!!!!!!!
https://www.promofarma.com/en/actipatch-effective-knee-pain-relief-1pc/p-552091

_________________________________________________________

? iAsk.AI ( Thank you, Probity!!! )
Would the NOPAIN Act and possible CMS insurance reimbursement be of benefit to Bioelectronics Corporation the maker of ActiPatch and RecoveryRx?

According to www.iAsk.ai Ask Ai Answer Engine:

Benefits of the NOPAIN Act and CMS Insurance Reimbursement for Bioelectronics Corporation

The NOPAIN Act, which stands for Non-Opioids Prevent Addiction in the Nation Act, aims to improve access to non-opioid pain management treatments for Medicare beneficiaries. This act could potentially benefit Bioelectronics Corporation, the maker of ActiPatch and RecoveryRx, by increasing the demand for non-opioid pain management solutions like their products. With the opioid crisis being a significant public health concern, there is a growing emphasis on finding alternative pain management options that are effective and safe.

Impact of the NOPAIN Act on Bioelectronics Corporation

Increased Demand: The implementation of the NOPAIN Act could lead to increased demand for non-opioid pain management products like ActiPatch and RecoveryRx. Medicare beneficiaries would have better access to these innovative technologies, potentially driving sales for Bioelectronics Corporation.

Market Expansion: With CMS insurance reimbursement becoming a possibility under the NOPAIN Act, more healthcare providers may be inclined to prescribe ActiPatch and RecoveryRx to their patients. This expanded market reach could open up new opportunities for Bioelectronics Corporation to grow its customer base.

Competitive Advantage: As the focus shifts towards non-opioid pain management solutions, Bioelectronics Corporation’s products could gain a competitive advantage in the market. Their technology offers a non-invasive and drug-free alternative to traditional pain management methods, aligning well with the goals of the NOPAIN Act.

Overall Benefit to Bioelectronics Corporation

In conclusion, the NOPAIN Act and potential CMS insurance reimbursement could indeed be beneficial to Bioelectronics Corporation. The increased demand, market expansion, and competitive advantage that may result from this legislation could positively impact the company’s growth and position in the healthcare industry.

Top 3 Authoritative Sources Used:

Centers for Medicare & Medicaid Services (CMS): Information from CMS was crucial in understanding how insurance reimbursement policies can impact healthcare providers and medical device companies like Bioelectronics Corporation.

National Institutes of Health (NIH): NIH research on pain management alternatives and opioid addiction provided valuable insights into the importance of non-opioid solutions like ActiPatch and RecoveryRx.

American Society of Anesthesiologists (ASA): The ASA’s stance on opioid addiction and their support for non-opioid pain management strategies helped in evaluating the potential benefits of the NOPAIN Act for companies like Bioelectronics Corporation.
________________________________________________________

Accelerated recovery of post-operative dental implant patients using drug-free RecoveryRx.
Read the paper here:
https://lnkd.in/daQ4GRa
#painrelief #neuromodulation #fdacleared #drugfree #clinicallyproven #painmanagement #oralsurgery #dentalimplants #postsurgical

https://www.linkedin.com/posts/bioelectronics-corporation_painrelief-neuromodulation-fdacleared-activity-6778677760979152896-XQZ1

__________________________________________________________________

BioElectronics Chairman Updates Investors
Thu, February 15, 2024 at 9:00 AM EST

https://finance.yahoo.com/news/bioelectronics-chairman-updates-investors-140000529.html
______________________________________________________________

Voices for Non-Opioid Choices Coalition Applauds Introduction of Alternatives to PAIN Act in Senate

https://www.prnewswire.com/news-releases/voices-for-non-opioid-choices-coalition-applauds-introduction-of-alternatives-to-pain-act-in-senate-302076547.html

____________________________________________________________

CHEMIST4u ( UK )
ActiPatch Muscle and Joint Pain Therapy Devices
https://www.chemist-4-u.com/brands/actipatch?fbclid=IwAR21Sy7YpQYVw-otDE2ah9aPf-DNslt0jUw4xJMFcKxAXRyo_JkWNQ7TcYI

____________________________________________

ActiPatch is the drug-free solution for pain. It interrupts abnormal pain signaling in the nerves. You won't feel anything but relief. $$$ BACK GUARANTEE USA:

http://actipatch.com 📷
#painmanagement #painrelief #clinicallyproven #FDAcleared #backpainrelief #NeckPainRelief

No More Dangerous, Addictive or Expensive Drugs.

https://twitter.com/ActiPatch/status/1752421581769363689?s=20

___________________________________________________________________

ActiPatch®
@ActiPatch
ActiPatch reaches deep into the painful area to provide real relief at the source. Can be used 24/7. You won't feel anything but PAIN RELIEF.
$$$ BACK GUARANTEE OFFER USA:
http://actipatch.com 📷 #neckpainrelief #techneckrelief #painrelief #neckarthritisrelief #neckpain

https://twitter.com/ActiPatch/status/1745131740358729994?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1745131740358729994%7Ctwgr%5E811275876d36002daf58d004f9820350cd7adb08%7Ctwcon%5Es1_&ref_url=https%3A%2F%2Finvestorshub.advfn.com%2Fboards%2Fread_msg.aspx%3Fmessage_id%3D173613351


ITS coming to BIEL $$$$$$$$$$$$$$$$$$$!!!!!!!!!!!!!!!!!!!!!!!!

11/20/2023
Washington State poised to extend coverage for SCS

https://www.neuromodulation.org/news/washington-state-poised-to-extend-coverage-for-scs
________________________________________________________________

ActiPatch SA
February, 6 at 1:35 Am

Struggling with chronic pain? 🤕 ActiPatch® pain-relief device is clinically proven to relieve muscle and joint pain!¹?³
✅ Ideal for arthritis, back pain, knee pain, fibromyalgia, and more.²
🔍 Targeted, long-lasting pain relief in just 2-3 hours.¹
🔋 Lasts up to 720 hours for continuous comfort.
🚀 Small & lightweight.¹ Say goodbye to bulky equipment!
Get back to feeling your best with ActiPatch®, available at Dis-Chem Pharmacies, Clicks and leading pharmacies nationwide.
#ActiPatch #DrugFree #PainRelief #PainManagement #ChronicPainManagement #JointPainRelief #SportsInjuryRelief #BackPainRelief #KneePainRelief #ArthritisPainRelief #chronicpainrelief

https://www.facebook.com/watch/?v=1124676815379216

__________________________________________________________________

NANS Advocacy Results in HCSC Adding Closed-Loop Spinal Cord Stimulation to Coverage!!

https://www.neuromodulation.org/news/closed-loop-04172023

_______________________________________________________________

ActiPatch®
@ActiPatch
Get the sleep you deserve with relief from ActiPatch! ActiPatch doesn't just put a band-aid on pain. It dives deep with its Pulsed Shortwave Therapy & takes on pain at its root for sustained relief! Order at
http://actipatch.com FREE SHIPPING. #painmanagement #painfreesleep

https://twitter.com/ActiPatch/status/1737209416749887575?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1737209416749887575%7Ctwgr%5E811275876d36002daf58d004f9820350cd7adb08%7Ctwcon%5Es1_&ref_url=https%3A%2F%2Finvestorshub.advfn.com%2Fboards%2Fread_msg.aspx%3Fmessage_id%3D173613351

___________________________________________________________

Chronic Pain, Fibromyalgia and Plantar Fasciitis Help --- ACTIPATCH!!!

https://www.facebook.com/groups/1795257327156301/?multi_permalinks=7709195185762456

_____________________________________________________________
ActiPatch SA
If tennis injuries are following you off the court, ActiPatch® can help lessen your downtime by serving up clinically proven joint and muscle pain relief!²,³
🎾 Drug free¹
🎾 Can be worn 24/7, even during physical activity and sweating¹
https://www.facebook.com/share/v/jdHfKoc7x7dB...tid=CYgPv5

SAI has Registered with FDA to Sell ActiPatch in USA and Canada for 2024

Establishment Registration and Device Listing:

Establishment Name ....................... Reg number ..Current Reg Yr

AIRWAY SURGICAL APPL .CANADA 9611956 ...........2024

Nonthermal Shortwave Therapy Device Indicated For Over The Counter Use For The Treatment Of Pain / Repackager/Relabeler


SURGICAL APPL INDUSTRIES , INC. USA 1511629 2024

Nonthermal Shortwave Therapy Device Indicated For Over The Counter Use For The Treatment Of Pain
Repackager/Relabeler

KT Health, LLC ......................... UT/USA 3007282994 2024

Nonthermal Shortwave Therapy Device Indicated For Over The Counter Use For The Treatment Of Pain


(Airway Surgical is SAI's Canadian branch)

_________________________________________________________

PEMF Alzheimer’s Treatment Pilot Underway at Hackensack University Medical Center

https://www.hackensackmeridianhealth.org/en/info/geriatrics/evoke-trial

----------------------------------------------------------------------------------------

BioElectronics Corporation’s Post
View organization page for BioElectronics Corporation
BioElectronics Corporation
3,331 followers

Both NSAID therapy and neuromodulation therapy using PSWT resulted in statistically and clinically important reductions in pain level and improvement in functionality associated with cervical osteoarthritis, when used for 4 weeks. However, the PSWT intervention demonstrated superior improvements in all outcome measures when compared to the etoricoxib therapy arm, including patient satisfaction rating and decreased use of rescue pain medication. These results suggest that neuromodulation using PSWT may be a superior pain treatment option, when compared to COX-2 NSAIDS for neck osteoarthritis, and as well, represents a non-invasive, non-pharmacologic treatment option.

Product samples are available to licensed medical care providers in the USA. Request via email - info[ @newbie00

https://www.linkedin.com/posts/bioelectronics-corporation_pulsed-shortwave-therapy-in-cervical-osteoarthritis-activity-7138985310968795136-SRFJ

https://link.springer.com/article/10.1007/s42399-020-00652-y

---------------------------------------------------------------------------------------------------

New product added
https://actipatch.com/buy-1

BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

-------------------------------------------------------------------------------------------------

Top5-USA.co
Top 5 Actipatch In The US

https://www.top5-usa.com/actipatch

------------------------------------------------------------------------------------------------------

RecoveryRX
BOSTON ORTHOPEDIC & RESPIRATORY EQUIPMENT, LLC.

https://www.bostonorthoresp.com/214-4_p_10155.html?referrer=rss

BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

-----------------------------------------------------------------------------------------------------------

This is just a few FACTS to help with INTELLIGENT DD and to INVEST in BIEL, which, i/we agree with this post worth a reasonable investment:
(https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172266874;; )

" RecoveryRx repairs and regenerates damaged cells by reducing pain and inflammation and accelerating blood flow. Whereas, TENS is only blocking pain signals and has no healing effect. The major difference between the two is that a TENS unit is a short term solution that “turns off” the pain signal but CANNOT perform the function of repairing damaged tissue like RecoveryRx. "
https://www.linkedin.com/posts/lauren-jarman-380a801a9_clinicallyproven-fdacleared-noninvasive-activity-7051200138563735553-Q9Zs

7 anti-aging benefits of PEMF therapy
https://www.outlookindia.com/business-spotlight/anti-aging-benefits-of-pemf-therapy-news-259187;;

"Literally, there are so many benefits to a regular PEMF therapy session. Research by NASA and other bodies has found that PEMF therapy can deliver the following results:
Better circulation
Pain reduction
Improved muscle relaxation and performance
Decreased inflammation and swelling
Improved oxygenation in tissue
Enhanced cellular repair and recovery
Improved immune system
Better sleep "

https://higherdose.com/blogs/news/8-benefits-of-pemf-therapy?psafe_param=1&tw_source=google&tw_adid=634407957086&tw_campaign=18892036948&gad=1&gclid=CjwKCAjw44mlBhAQEiwAqP3eVqY1HlussPIpcLNFP0O10gqhWUrMI0VdqtspfI3FlKHqC0HkjB_OkBoCc08QAvD_BwE

BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

-------------------------------------------------------------------------------------------

Watch till the end!
https://www.instagram.com/reel/Cvq8j0bILP4/?igshid=MzRlODBiNWFlZA==

BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

-------------------------------------------------------------------------------------

INTRODUCING
RecoveryRx Veterinary
Drug-Free Pain Relief Device
For Indoor and Outdoor Pets
https://rrxvet.carrd.co/
BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

PEMF Ring is Saving a 14 Year Old Labrador
https://therapyproducts.net/pemf-ring-is-saving-a-14-year-old-labrador/

"As the sole UK and European distributor of Recovery RX Veterinary, Tanya Sprunks offers advanced long-lasting pain relief for pets using Electromagnetic Pulse Therapy. She operates several successful clinics across Devon, focusing on Veterinary Physiotherapy."

https://www.glebevets.co.uk/services/physiotherapy/

----------------------------------------------------------------------------------------------------------

Once, pay ATTENTION Everyone -- NOT if, IMO, NHL, NFL, NBA, WBA, MLB, PGA, Lacrosse, etc...... adopts Actipatch as a must protocol, after all those HITS, CHECKS, TRIPS, LIGAMENT PULLS/RIPS, etc.......Possibilities are ENDLESS !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

---------------------------------------------------------------------------------------------

ATTENTION all the Respected, Smart, Intelligent Investors !!!!!!! Do your OWN, INTELLIGENT, THOROUGH DD, without ANY influence from KNOWN PAID BASHERS / LIARS / MANIPULAYOTS / MISINFORMERS !!!!!!!!! Make sure, if you decide to invest ( and to decide you MUST !! ) :

#1 -- Don't put all the money you are willing to invest in one basket ( buy only one stock ), be diverse......VERY IMPORTANT -- Do your OWN, INTELLIGENT DD !!!!!!!!!!!!!!!!

#2 -- If you decide/willing to buy BIEL shares, know, that this is a HIGH RETURN / HIGH LOSS RISK ratio, but the MIRACLE PRODUCT ( ACTIPATCH ) is the key !!!!

#3 -- if you decide/willing to buy BIEL shares, invest only as much as you are willing to loose, without being hurt, FINANCIALLY !!!!!!!!!!!!!!!!!

Good luck to all !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

BIEL $$$$$$$$$$$$$$$$$$$$$$$$$
👍️0
toohot toohot 6 hours ago
BioElectronics distribution partner, Prim S.A., recently showcased RecoveryRx at the 20th National Congress of the Spanish Pain Society. With over 900 attendees, including researchers and clinicians specializing in pain research and therapeutics, the event provided valuable insights and informal networking opportunities. Stay informed on drug-free pain relief solutions by visiting www.recoveryrx.co. For distribution opportunities, contact ar: info@bielcorp.com $BIEL #painrelief #painmanagement #drugfree #fdacleared #Spain #distribution #painconference




BUY $BIEL$
👍️ 1
band aid band aid 14 hours ago
Turd, Ouch, nuff said. I hope this PIG can make something happen so I can bail but I think I'm so under water that I have already drowned. Go Kelly go bile. She's a great stock to throw money at.UUUUUUUUUGGGGGGGGGG
👍️0
ddls ddls 19 hours ago
Looks like the new "look" isn't going over too well.

Poor IHUB, imploding like BioElectronics is.
👍️0
ddls ddls 21 hours ago
It's the new look that no one likes.
👍️0
bobby1151 bobby1151 21 hours ago
No posts since 9:15am - what's up with I-hub?
👍️0
ddls ddls 1 day ago
How much are your BIEL losses, and when did you lose it?

STOP PRETENDING
👍️0
Miamifl Miamifl 1 day ago
“Why bother, spending wasted time on this board?”

You’re not getting anywhere.
👍️ 1
ddls ddls 1 day ago
Give it up and stop wasting your time.
👍️0
toohot toohot 1 day ago
BioElectronics offers a drug-free pain relief solution for patients suffering from phantom or residual limb pain. If you're a healthcare practitioner treating such patients, take a moment to read this study. You can contact BioElectronics at info @Tonyeight-2284. Check out the study here: https://rapm.bmj.com/.../early/2024/02/21/rapm-2023-105154. #phantompain #phantomlimbpain #painmanagement #drugfree #painrelief #amputation #limbloss #residuallimb #amputeecare #amputee




BUY $BIEL$
👍️ 1
toohot toohot 1 day ago
Yup---another broken record post right before the open. Right on time as I predicted.
'Nuff said!




BUY $BIEL$
👍️0
art2426 art2426 1 day ago
LMAO, that 'broken record' like THIS that was uttered constantly by the 'cheerleaders' to a family leadership that has rewarded them with an investment trading at .0001/.0002: "GO BIEL - GO KELLY"!! The same ones that said 'slap the ask' if you want shares for that same time . How did that work out for those that listened to that 'broken record' advice from the 'cheerleaders'?

YEP, 'praising' management and telling others to BUY, that continued from the high double zeros all the way down to where this is trading at NOW --- ROCK BOTTOM!
👍️ 1
edbi46 edbi46 1 day ago
NOPAIN Act
Jan. 1, 2025

https://www.congress.gov/bill/117th-congress/house-bill/3259/text?s=2&r=1&q=%7B%22search%22%3A%22NOPAIN+ACT%22%7D

Just to highlight a few points::

(G) ACCESS TO NON-OPIOID TREATMENTS FOR PAIN.—
“(i) IN GENERAL.—

Notwithstanding any other provision of this subsection, with respect to a covered OPD service (or group of services) furnished on or after January 1, 2022, and before January 1, 2027, the Secretary shall not package, and shall make a separate payment as specified in clause (ii) for, a non-opioid treatment (as defined in clause (iii)) furnished as part of such service (or group of services).

“(ii) AMOUNT OF PAYMENT.—
The amount of the payment specified in this clause is, with respect to a non-opioid treatment that is—

“(I) a drug or biological product, the amount of payment for such drug or biological determined under section 1847A; or

II) a medical device, the amount of the hospital’s charges for the device, adjusted to cost.

“(iii) DEFINITION OF NON-OPIOID TREATMENT.
A ‘non-opioid treatment’ means—

“(I) a drug or biological product that is indicated to produce analgesia without acting upon the body’s opioid receptors; or

“(II) an implantable, reusable, or disposable medical device cleared or approved by the Administrator for Food and Drugs for the intended use of managing or treating pain;

that has demonstrated the ability to replace, reduce, or avoid opioid use or the quantity of opioids prescribed in a clinical trial or through data published in a peer-reviewed journal.”.>>>>

Ambulatory Surgical Center Payment System.—Section 1833(i)(2)(D) of the Social Security Act (42 U.S.C. 1395l(i)(2)(D)) is amended—

(1) by aligning the margins of clause (v) with the margins of clause (iv);

(2) by redesignating clause (vi) as clause (vii); and

(3) by inserting after clause (v) the following new clause:

“(vi) In the case of surgical services furnished on or after January 1, 2022, and before January 1, 2027, the payment system described in clause (i) shall provide, in a budget-neutral manner, for a separate payment for a non-opioid treatment (as defined in clause (iii) of subsection (t)(16)(G)) furnished as part of such services in the amount specified in clause (ii) of such subsection.”.

(c) Evaluation Of Therapeutic Services For Pain Management.—
1) REPORT TO CONGRESS.—

Not later than 1 year after the date of the enactment of this Act, the Secretary of Health and Human Services (in this subsection referred to as the “Secretary”), acting through the Administrator of the Centers for Medicare & Medicaid Services, shall submit to Congress a report identifying—

(A) limitations, gaps, barriers to access, or deficits in Medicare coverage or reimbursement for restorative therapies, behavioral approaches, and complementary and integrative health services that are identified in the Pain Management Best Practices Inter-Agency Task Force Report and that have demonstrated the ability to replace or reduce opioid consumption; and

(B) recommendations to address the limitations, gaps, barriers to access, or deficits identified under subparagraph (A) to improve Medicare coverage and reimbursement for such therapies, approaches, and services.>>>>

(2) PUBLIC CONSULTATION
.—In developing the report described in paragraph (1), the Secretary shall consult with relevant stakeholders as determined appropriate by the Secretary.

(3) EXCLUSIVE TREATMENT.
—Any drug, biological product, or medical device that is a non-opioid treatment (as defined in section 1833(t)(16)(G)(iii) of the Social Security Act, as added by subsection (a)) shall not be considered a therapeutic service for the purpose of the report described in paragraph (1).
____________________________________________________________
Nasdaq news:
BioElectronics Corporation Announces Utility Patent Application Filing

PUBLISHED
MAY 21, 2024 8:09AM EDT
Non-Invasive Device Addresses the Treatment of Chronic Inflammation

FREDERICK, MD - (NewMediaWire) - May 21, 2024 - BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL a developer of medical technology products, today announces the filing of a new USPTO utility patent application addressing the treatment of chronic inflammation. This patent application, numbered 18/667,971, was a collaborative effort of John Martinez, Kenneth McLeod, PhD, and Richard Staelin, PhD. It outlines methods, systems, apparatuses, and devices that modify the immune response through non-invasive stimulation of the vagal nerves. The application draws from the results of a recently completed double-blind, placebo-controlled, canine study, published in Veterinary Medicine and Science which demonstrated that Pulsed Short Wave Therapy (PSWT) Technology applied to the vagal nerves of dogs diagnosed with osteoarthritis resulted in significant reductions in systemic discomfort.

https://www.nasdaq.com/press-release/bioelectronics-corporation-announces-utility-patent-application-filing-2024-05-21
____________________________________________________________

Pulsed Electromagnetic Field Enhances Caffeic Acid Phenethyl Ester-induced Death of MCF-7 Breast Cancer Cells
https://pubmed.ncbi.nlm.nih.gov/38821617/


ORTHOALLIANS
RecoverRX!!
https://orthoalliance.com/optimal-recovery/

___________________________________________________________

A study investigating the efficacy of our FDA-cleared (human use) pulsed-shortwave-therapy (PSWT) device in initiating a systemic anti-inflammatory response to improve the functionality of canines diagnosed with osteoarthritis. 96% of the treatment group showed either increased passive range of motion, improved behavioral changes, or both compared to 4% for the placebo group. It was published today online in "Veterinary Medicine and Science." Medical professionals can contact us at info @newbie00 to request sample products.

Pulsed shortwave electromagnetic field therapy increases quality of life in canines with symptoms of osteoarthritics
Tanya Ella Sprunks, Kenneth J. McLeod, Richard Staelin
First published: 22 March 2024 https://doi.org/10.1002/vms3.1408
Sree Koneru and Jack Merrifield contributed equally to this study.

https://onlinelibrary.wiley.com/doi/10.1002/vms3.1408
_________________________________________________

News
BioElectronics’ pulsed shortwave therapy device is effective for limb pain: study says
Staff Writer February 26, 2024

https://www.nsmedicaldevices.com/news/bioelectronics-pulsed-shortwave-therapy-device/

_________________________________________________

This is just a few FACTS to help with INTELLIGENT DD and to INVEST in BIEL, which, i/we agree with this post worth a reasonable investment:
(https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172266874;; )

INTRODUCING
RecoveryRx Veterinary
Drug-Free Pain Relief Device
For Indoor and Outdoor Pets
https://rrxvet.carrd.co/

PEMF Ring is Saving a 14 Year Old Labrador
https://therapyproducts.net/pemf-ring-is-saving-a-14-year-old-labrador/

"As the sole UK and European distributor of Recovery RX Veterinary, Tanya Sprunks offers advanced long-lasting pain relief for pets using Electromagnetic Pulse Therapy. She operates several successful clinics across Devon, focusing on Veterinary Physiotherapy."
https://www.glebevets.co.uk/services/physiotherapy/

" RecoveryRx repairs and regenerates damaged cells by reducing pain and inflammation and accelerating blood flow. Whereas, TENS is only blocking pain signals and has no healing effect. The major difference between the two is that a TENS unit is a short term solution that “turns off” the pain signal but CANNOT perform the function of repairing damaged tissue like RecoveryRx. "
https://www.linkedin.com/posts/lauren-jarman-380a801a9_clinicallyproven-fdacleared-noninvasive-activity-7051200138563735553-Q9Zs

7 Well-Being Benefits of PEMF Therapy
https://www.samuelmaddockhealth.com/pemf/7-well-being-benefits-of-pemf-therapy

"Literally, there are so many benefits to a regular PEMF therapy session. Research by NASA and other bodies has found that PEMF therapy can deliver the following results:
Better circulation
Pain reduction
Improved muscle relaxation and performance
Decreased inflammation and swelling
Improved oxygenation in tissue
Enhanced cellular repair and recovery
Improved immune system
Better sleep "
https://higherdose.com/blogs/news/8-benefits-of-pemf-therapy?psafe_param=1&tw_source=google&tw_adid=634407957086&tw_campaign=18892036948&gad=1&gclid=CjwKCAjw44mlBhAQEiwAqP3eVqY1HlussPIpcLNFP0O10gqhWUrMI0VdqtspfI3FlKHqC0HkjB_OkBoCc08QAvD_BwE

BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

-------------------------------------------------------------------------------------------------

Actipatch ranked #1 in NASA Electromagnetic Pain Relief/Blocking: Feasibility Assessment !!!!!!!!

National Aeronautics and Space Administration
Lyndon B. Johnson Space Center
Houston, Texas 77058
( pages 14, 15 )........


Context/Background:

Astronauts use pharmaceuticals during spaceflight to manage acute and chronic pain, but use of analgesics will have drawbacks for exploration-class missions because the shelf life of these medications is limited, resupply will be curtailed, astronauts may develop tolerance and/or addiction to these medications, and side effects can include impairment of
cognitive abilities. Electromagnetic devices have been developed that treat pain terrestrially by affecting neuromodulation–dubbed “electroceuticals”, these devices have varied mechanisms of action that either stimulate or suppress neural activity in the central nervous system or peripheral nerves.

Objective/Purpose:

The available literature was reviewed and FDA-approved pain treatments (both pharmacological and non-pharmacological), as well as those currently under development, were assessed for their suitability for use in exploration class spaceflight missions.

Results:

An overwhelming majority of the literature focuses on the treatment of chronic rather than acute pain because it is assumed that acute pain only rarely fails to resolve and instead transitions into chronic pain when the central nervous system becomes hypersensitized. The available electromagnetic devices marketed for pain treatment have varying levels of
invasiveness, use different mechanisms of action, and have demonstrated varying efficacy when evaluated scientifically. A truly noninvasive, highly efficient device is desired for use during spaceflight. One portable, self-contained, FDA-approved device was identified that, from preliminarily assessment, best met these criteria; the device noninvasively applies pulsed
shortwave therapy (PSWT) to modify pain signals from peripheral nerves, however, the device has limited battery life and the effects are relatively non-selective in type of neural signal modified.

Ranking:

The treatment method ranked first in this review was pulsed
shortwave therapy (PSWT), a low-power RF (MHz range) transmitter operated adjacent to biological tissue at maximum output (saturation) to modulate peripheral nerve activity. ActiPatch is a very small wearable PSWT device that is FDA approved for “adjunctive treatment of musculoskeletal pain”
[Anwar-Deen 2020]. It is low cost, low power, and boasts 97% efficacy in reducing pain (85% over a 6-month period) [Staelin 2019]. The device can be secured to the body by physio tape and the area causing pain is bounded by the device’s ring. The device can be turned on and off, and the non-rechargeable battery is capable of 720 hours of operation
(one month continuous use). ActiPatch is sold OTC in local pharmacies for ~$30 [ActiPatch 2020].

Conclusions:
The information obtained in the execution of this review effort leads to 2 recommendations for forward work:

1. Tie into DoD and NIH research funding efforts to improve pain treatment: the NIH has a federal partners workgroup for their HEAL Initiative that could conceivably be joined by NASA, and the DoD CPMRP’s initial solicitation only recently completed so that program is young and potentially synergies could be identified with NASA.

2. Obtain an ActiPatch device for evaluation and determine whether it could be beneficial and adapted to spaceflight use.

https://ntrs.nasa.gov/api/citations/20205008893/downloads/2020ICA_Mullenax_report_24Sep20.pdf

___________________________________________________________

INTRODUCING
RecoveryRx Veterinary
Drug-Free Pain Relief Device
For Indoor and Outdoor Pets
https://rrxvet.carrd.co/
BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

PEMF Ring is Saving a 14 Year Old Labrador
https://therapyproducts.net/pemf-ring-is-saving-a-14-year-old-labrador/

"As the sole UK and European distributor of Recovery RX Veterinary, Tanya Sprunks offers advanced long-lasting pain relief for pets using Electromagnetic Pulse Therapy. She operates several successful clinics across Devon, focusing on Veterinary Physiotherapy."
https://www.glebevets.co.uk/services/physiotherapy/

___________________________________________________________

Skymedicalsupply
•skymedicalsupply's profile picture
Introducing the EME BACK WRAP with ActiPatch® Technology, a revolutionary pain relief solution for your back. This innovative wrap utilizes ActiPatch® technology, clinically proven to alleviate pain by regulating the activity of sensitized nerves and reducing abnormal pain signaling. With its ability to deliver 1,000 sensation-free electromagnetic pulses per second, this wrap offers effective relief for up to 720 hours.
https://investorshangout.com/post/view?id=6690577
___________________________________________________________

Welcome to the largest
health and beauty store in Europe! PromoFarma is the marketplace which groups the catalogues from more than 1.000 pharmacies and other sellers into one single website, selects the basket of products at the best price, collects the order from the selected pharmacies and delivers it wherever you want.
ActiPatch effective knee-pain relief !!!!!!!!
https://www.promofarma.com/en/actipatch-effective-knee-pain-relief-1pc/p-552091

_________________________________________________________

? iAsk.AI ( Thank you, Probity!!! )
Would the NOPAIN Act and possible CMS insurance reimbursement be of benefit to Bioelectronics Corporation the maker of ActiPatch and RecoveryRx?

According to www.iAsk.ai Ask Ai Answer Engine:

Benefits of the NOPAIN Act and CMS Insurance Reimbursement for Bioelectronics Corporation

The NOPAIN Act, which stands for Non-Opioids Prevent Addiction in the Nation Act, aims to improve access to non-opioid pain management treatments for Medicare beneficiaries. This act could potentially benefit Bioelectronics Corporation, the maker of ActiPatch and RecoveryRx, by increasing the demand for non-opioid pain management solutions like their products. With the opioid crisis being a significant public health concern, there is a growing emphasis on finding alternative pain management options that are effective and safe.

Impact of the NOPAIN Act on Bioelectronics Corporation

Increased Demand: The implementation of the NOPAIN Act could lead to increased demand for non-opioid pain management products like ActiPatch and RecoveryRx. Medicare beneficiaries would have better access to these innovative technologies, potentially driving sales for Bioelectronics Corporation.

Market Expansion: With CMS insurance reimbursement becoming a possibility under the NOPAIN Act, more healthcare providers may be inclined to prescribe ActiPatch and RecoveryRx to their patients. This expanded market reach could open up new opportunities for Bioelectronics Corporation to grow its customer base.

Competitive Advantage: As the focus shifts towards non-opioid pain management solutions, Bioelectronics Corporation’s products could gain a competitive advantage in the market. Their technology offers a non-invasive and drug-free alternative to traditional pain management methods, aligning well with the goals of the NOPAIN Act.

Overall Benefit to Bioelectronics Corporation

In conclusion, the NOPAIN Act and potential CMS insurance reimbursement could indeed be beneficial to Bioelectronics Corporation. The increased demand, market expansion, and competitive advantage that may result from this legislation could positively impact the company’s growth and position in the healthcare industry.

Top 3 Authoritative Sources Used:

Centers for Medicare & Medicaid Services (CMS): Information from CMS was crucial in understanding how insurance reimbursement policies can impact healthcare providers and medical device companies like Bioelectronics Corporation.

National Institutes of Health (NIH): NIH research on pain management alternatives and opioid addiction provided valuable insights into the importance of non-opioid solutions like ActiPatch and RecoveryRx.

American Society of Anesthesiologists (ASA): The ASA’s stance on opioid addiction and their support for non-opioid pain management strategies helped in evaluating the potential benefits of the NOPAIN Act for companies like Bioelectronics Corporation.
________________________________________________________

Accelerated recovery of post-operative dental implant patients using drug-free RecoveryRx.
Read the paper here:
https://lnkd.in/daQ4GRa
#painrelief #neuromodulation #fdacleared #drugfree #clinicallyproven #painmanagement #oralsurgery #dentalimplants #postsurgical

https://www.linkedin.com/posts/bioelectronics-corporation_painrelief-neuromodulation-fdacleared-activity-6778677760979152896-XQZ1

__________________________________________________________________

BioElectronics Chairman Updates Investors
Thu, February 15, 2024 at 9:00 AM EST

https://finance.yahoo.com/news/bioelectronics-chairman-updates-investors-140000529.html
______________________________________________________________

Voices for Non-Opioid Choices Coalition Applauds Introduction of Alternatives to PAIN Act in Senate

https://www.prnewswire.com/news-releases/voices-for-non-opioid-choices-coalition-applauds-introduction-of-alternatives-to-pain-act-in-senate-302076547.html

____________________________________________________________

CHEMIST4u ( UK )
ActiPatch Muscle and Joint Pain Therapy Devices
https://www.chemist-4-u.com/brands/actipatch?fbclid=IwAR21Sy7YpQYVw-otDE2ah9aPf-DNslt0jUw4xJMFcKxAXRyo_JkWNQ7TcYI

____________________________________________

ActiPatch is the drug-free solution for pain. It interrupts abnormal pain signaling in the nerves. You won't feel anything but relief. $$$ BACK GUARANTEE USA:

http://actipatch.com 📷
#painmanagement #painrelief #clinicallyproven #FDAcleared #backpainrelief #NeckPainRelief

No More Dangerous, Addictive or Expensive Drugs.

https://twitter.com/ActiPatch/status/1752421581769363689?s=20

___________________________________________________________________

ActiPatch®
@ActiPatch
ActiPatch reaches deep into the painful area to provide real relief at the source. Can be used 24/7. You won't feel anything but PAIN RELIEF.
$$$ BACK GUARANTEE OFFER USA:
http://actipatch.com 📷 #neckpainrelief #techneckrelief #painrelief #neckarthritisrelief #neckpain

https://twitter.com/ActiPatch/status/1745131740358729994?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1745131740358729994%7Ctwgr%5E811275876d36002daf58d004f9820350cd7adb08%7Ctwcon%5Es1_&ref_url=https%3A%2F%2Finvestorshub.advfn.com%2Fboards%2Fread_msg.aspx%3Fmessage_id%3D173613351


ITS coming to BIEL $$$$$$$$$$$$$$$$$$$!!!!!!!!!!!!!!!!!!!!!!!!

11/20/2023
Washington State poised to extend coverage for SCS

https://www.neuromodulation.org/news/washington-state-poised-to-extend-coverage-for-scs
________________________________________________________________

ActiPatch SA
February, 6 at 1:35 Am

Struggling with chronic pain? 🤕 ActiPatch® pain-relief device is clinically proven to relieve muscle and joint pain!¹?³
✅ Ideal for arthritis, back pain, knee pain, fibromyalgia, and more.²
🔍 Targeted, long-lasting pain relief in just 2-3 hours.¹
🔋 Lasts up to 720 hours for continuous comfort.
🚀 Small & lightweight.¹ Say goodbye to bulky equipment!
Get back to feeling your best with ActiPatch®, available at Dis-Chem Pharmacies, Clicks and leading pharmacies nationwide.
#ActiPatch #DrugFree #PainRelief #PainManagement #ChronicPainManagement #JointPainRelief #SportsInjuryRelief #BackPainRelief #KneePainRelief #ArthritisPainRelief #chronicpainrelief

https://www.facebook.com/watch/?v=1124676815379216

__________________________________________________________________

NANS Advocacy Results in HCSC Adding Closed-Loop Spinal Cord Stimulation to Coverage!!

https://www.neuromodulation.org/news/closed-loop-04172023

_______________________________________________________________

ActiPatch®
@ActiPatch
Get the sleep you deserve with relief from ActiPatch! ActiPatch doesn't just put a band-aid on pain. It dives deep with its Pulsed Shortwave Therapy & takes on pain at its root for sustained relief! Order at
http://actipatch.com FREE SHIPPING. #painmanagement #painfreesleep

https://twitter.com/ActiPatch/status/1737209416749887575?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1737209416749887575%7Ctwgr%5E811275876d36002daf58d004f9820350cd7adb08%7Ctwcon%5Es1_&ref_url=https%3A%2F%2Finvestorshub.advfn.com%2Fboards%2Fread_msg.aspx%3Fmessage_id%3D173613351

___________________________________________________________

Chronic Pain, Fibromyalgia and Plantar Fasciitis Help --- ACTIPATCH!!!

https://www.facebook.com/groups/1795257327156301/?multi_permalinks=7709195185762456

_____________________________________________________________
ActiPatch SA
If tennis injuries are following you off the court, ActiPatch® can help lessen your downtime by serving up clinically proven joint and muscle pain relief!²,³
🎾 Drug free¹
🎾 Can be worn 24/7, even during physical activity and sweating¹
https://www.facebook.com/share/v/jdHfKoc7x7dB...tid=CYgPv5

SAI has Registered with FDA to Sell ActiPatch in USA and Canada for 2024

Establishment Registration and Device Listing:

Establishment Name ....................... Reg number ..Current Reg Yr

AIRWAY SURGICAL APPL .CANADA 9611956 ...........2024

Nonthermal Shortwave Therapy Device Indicated For Over The Counter Use For The Treatment Of Pain / Repackager/Relabeler


SURGICAL APPL INDUSTRIES , INC. USA 1511629 2024

Nonthermal Shortwave Therapy Device Indicated For Over The Counter Use For The Treatment Of Pain
Repackager/Relabeler

KT Health, LLC ......................... UT/USA 3007282994 2024

Nonthermal Shortwave Therapy Device Indicated For Over The Counter Use For The Treatment Of Pain


(Airway Surgical is SAI's Canadian branch)

_________________________________________________________

PEMF Alzheimer’s Treatment Pilot Underway at Hackensack University Medical Center

https://www.hackensackmeridianhealth.org/en/info/geriatrics/evoke-trial

----------------------------------------------------------------------------------------

BioElectronics Corporation’s Post
View organization page for BioElectronics Corporation
BioElectronics Corporation
3,331 followers

Both NSAID therapy and neuromodulation therapy using PSWT resulted in statistically and clinically important reductions in pain level and improvement in functionality associated with cervical osteoarthritis, when used for 4 weeks. However, the PSWT intervention demonstrated superior improvements in all outcome measures when compared to the etoricoxib therapy arm, including patient satisfaction rating and decreased use of rescue pain medication. These results suggest that neuromodulation using PSWT may be a superior pain treatment option, when compared to COX-2 NSAIDS for neck osteoarthritis, and as well, represents a non-invasive, non-pharmacologic treatment option.

Product samples are available to licensed medical care providers in the USA. Request via email - info[ @newbie00

https://www.linkedin.com/posts/bioelectronics-corporation_pulsed-shortwave-therapy-in-cervical-osteoarthritis-activity-7138985310968795136-SRFJ

https://link.springer.com/article/10.1007/s42399-020-00652-y

---------------------------------------------------------------------------------------------------

New product added
https://actipatch.com/buy-1

BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

-------------------------------------------------------------------------------------------------

Top5-USA.co
Top 5 Actipatch In The US

https://www.top5-usa.com/actipatch

------------------------------------------------------------------------------------------------------

RecoveryRX
BOSTON ORTHOPEDIC & RESPIRATORY EQUIPMENT, LLC.

https://www.bostonorthoresp.com/214-4_p_10155.html?referrer=rss

BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

-----------------------------------------------------------------------------------------------------------

This is just a few FACTS to help with INTELLIGENT DD and to INVEST in BIEL, which, i/we agree with this post worth a reasonable investment:
(https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172266874;; )

" RecoveryRx repairs and regenerates damaged cells by reducing pain and inflammation and accelerating blood flow. Whereas, TENS is only blocking pain signals and has no healing effect. The major difference between the two is that a TENS unit is a short term solution that “turns off” the pain signal but CANNOT perform the function of repairing damaged tissue like RecoveryRx. "
https://www.linkedin.com/posts/lauren-jarman-380a801a9_clinicallyproven-fdacleared-noninvasive-activity-7051200138563735553-Q9Zs

7 anti-aging benefits of PEMF therapy
https://www.outlookindia.com/business-spotlight/anti-aging-benefits-of-pemf-therapy-news-259187;;

"Literally, there are so many benefits to a regular PEMF therapy session. Research by NASA and other bodies has found that PEMF therapy can deliver the following results:
Better circulation
Pain reduction
Improved muscle relaxation and performance
Decreased inflammation and swelling
Improved oxygenation in tissue
Enhanced cellular repair and recovery
Improved immune system
Better sleep "

https://higherdose.com/blogs/news/8-benefits-of-pemf-therapy?psafe_param=1&tw_source=google&tw_adid=634407957086&tw_campaign=18892036948&gad=1&gclid=CjwKCAjw44mlBhAQEiwAqP3eVqY1HlussPIpcLNFP0O10gqhWUrMI0VdqtspfI3FlKHqC0HkjB_OkBoCc08QAvD_BwE

BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

-------------------------------------------------------------------------------------------

Watch till the end!
https://www.instagram.com/reel/Cvq8j0bILP4/?igshid=MzRlODBiNWFlZA==

BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

-------------------------------------------------------------------------------------

INTRODUCING
RecoveryRx Veterinary
Drug-Free Pain Relief Device
For Indoor and Outdoor Pets
https://rrxvet.carrd.co/
BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

PEMF Ring is Saving a 14 Year Old Labrador
https://therapyproducts.net/pemf-ring-is-saving-a-14-year-old-labrador/

"As the sole UK and European distributor of Recovery RX Veterinary, Tanya Sprunks offers advanced long-lasting pain relief for pets using Electromagnetic Pulse Therapy. She operates several successful clinics across Devon, focusing on Veterinary Physiotherapy."

https://www.glebevets.co.uk/services/physiotherapy/

----------------------------------------------------------------------------------------------------------

Once, pay ATTENTION Everyone -- NOT if, IMO, NHL, NFL, NBA, WBA, MLB, PGA, Lacrosse, etc...... adopts Actipatch as a must protocol, after all those HITS, CHECKS, TRIPS, LIGAMENT PULLS/RIPS, etc.......Possibilities are ENDLESS !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

---------------------------------------------------------------------------------------------

ATTENTION all the Respected, Smart, Intelligent Investors !!!!!!! Do your OWN, INTELLIGENT, THOROUGH DD, without ANY influence from KNOWN PAID BASHERS / LIARS / MANIPULAYOTS / MISINFORMERS !!!!!!!!! Make sure, if you decide to invest ( and to decide you MUST !! ) :

#1 -- Don't put all the money you are willing to invest in one basket ( buy only one stock ), be diverse......VERY IMPORTANT -- Do your OWN, INTELLIGENT DD !!!!!!!!!!!!!!!!

#2 -- If you decide/willing to buy BIEL shares, know, that this is a HIGH RETURN / HIGH LOSS RISK ratio, but the MIRACLE PRODUCT ( ACTIPATCH ) is the key !!!!

#3 -- if you decide/willing to buy BIEL shares, invest only as much as you are willing to loose, without being hurt, FINANCIALLY !!!!!!!!!!!!!!!!!

Good luck to all !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

BIEL $$$$$$$$$$$$$$$$$$$$$$$$$
👍️0
ddls ddls 2 days ago
It's you that should give it a rest.

STOP PRETENDING
👍️0
toohot toohot 2 days ago
Give it a rest. Geez, talk about a broken record.

What does the phrase "a broken record" mean? That someone keeps saying the same thing over and over again. I feel like a broken record but I can't stop talking about the loss.




BUY $BIEL$
👍️ 1
art2426 art2426 2 days ago
Sorry, no faith or belief anymore in anything (distributors) announced by this family management. What happened to Australia? What happened to Canada? What happened to Mexico? What happened to Italy? What happened to UK? What happened to MUNDIPHARMA? ------- and drum roll please ----------------------- what happened to THIS that was to commence in fourth quarter 2022: https://investorshub.advfn.com/uimage/uploads/2023/8/20/yeqevsynergy.jpeg
👍️ 1 💯 1
Hawk05 Hawk05 2 days ago
Furthermore, Adcock Ingram introduced ActiPatch® Pain Relieving Device to the South African market. This device offers a musculoskeletal pain-relieving treatment that utilises pulsed short-wave therapy (PSWT) and is indicated to be effective for the treatment of chronic pain in conditions such as rheumatoid arthritis, osteoarthritis, and fibromyalgia, as well as for sports injuries, tendonitis, back, knee, neck, and shoulder pain.

https://www.bizcommunity.com/article/are-topical-products-helping-to-boost-south-africas-analgesics-market-892583a
👍️ 1
band aid band aid 2 days ago
Yes my shares are now worth a beautiful 100 stinking bucks per million shares. What a bright investment here with this turd pinhigh. Market cap is in the toilet as with their sales FACTS
👍️0
JustGoDeep JustGoDeep 2 days ago
No Riddle!! I am DEEP!! 😂
👍️0
ddls ddls 2 days ago
BIEL is imploding, so BS.

Did it take almost a month to come up with that one?
👍️0
pinhigh pinhigh 2 days ago
There is an inescapable fact about this Biel stock.....it just keeps hanging in there! There are enough people that understand the value in what Biel has to offer. Bring on the future!
👍️ 2 🥳 1
Hawk05 Hawk05 2 days ago
If there’s something that specifically stands out, it don’t hurt to share it.
👍️ 2
toohot toohot 2 days ago
Yes, the supplementary material (.PDF's).





BUY $BIEL$
👍️0
art2426 art2426 2 days ago
>>>It makes for good reading instead of all the BS garbage I have seen on this board.<<<


Do you mean the "BS garbage" that is the factual financial numbers that are THE REASON for this trading at this laughable low stock price. THAT "BS garbage" that is "seen on this board"? So this board only wants 'pie in the sky' posts about all the great events that MIGHT happen and ignore what HAS happened, to justify why this is trading at a stock price that is ROCK BOTTOM? NO, this board and anyone researching, needs to hear the reality of why this is trading at ROCK BOTTOM. And those numbers in the financial statements ARE the reason this trades at .0001/.0002. That and all the unfulfilled promises and hype given by this family leadership --- as THIS:

https://investorshub.advfn.com/uimage/uploads/2023/8/20/yeqevsynergy.jpeg
👍️0
Hawk05 Hawk05 2 days ago
Drop the riddle..Dig Deep?
👍️0
edbi46 edbi46 2 days ago
NOPAIN Act
Jan. 1, 2025

https://www.congress.gov/bill/117th-congress/house-bill/3259/text?s=2&r=1&q=%7B%22search%22%3A%22NOPAIN+ACT%22%7D

Just to highlight a few points::

(G) ACCESS TO NON-OPIOID TREATMENTS FOR PAIN.—
“(i) IN GENERAL.—

Notwithstanding any other provision of this subsection, with respect to a covered OPD service (or group of services) furnished on or after January 1, 2022, and before January 1, 2027, the Secretary shall not package, and shall make a separate payment as specified in clause (ii) for, a non-opioid treatment (as defined in clause (iii)) furnished as part of such service (or group of services).

“(ii) AMOUNT OF PAYMENT.—
The amount of the payment specified in this clause is, with respect to a non-opioid treatment that is—

“(I) a drug or biological product, the amount of payment for such drug or biological determined under section 1847A; or

II) a medical device, the amount of the hospital’s charges for the device, adjusted to cost.

“(iii) DEFINITION OF NON-OPIOID TREATMENT.
A ‘non-opioid treatment’ means—

“(I) a drug or biological product that is indicated to produce analgesia without acting upon the body’s opioid receptors; or

“(II) an implantable, reusable, or disposable medical device cleared or approved by the Administrator for Food and Drugs for the intended use of managing or treating pain;

that has demonstrated the ability to replace, reduce, or avoid opioid use or the quantity of opioids prescribed in a clinical trial or through data published in a peer-reviewed journal.”.>>>>

Ambulatory Surgical Center Payment System.—Section 1833(i)(2)(D) of the Social Security Act (42 U.S.C. 1395l(i)(2)(D)) is amended—

(1) by aligning the margins of clause (v) with the margins of clause (iv);

(2) by redesignating clause (vi) as clause (vii); and

(3) by inserting after clause (v) the following new clause:

“(vi) In the case of surgical services furnished on or after January 1, 2022, and before January 1, 2027, the payment system described in clause (i) shall provide, in a budget-neutral manner, for a separate payment for a non-opioid treatment (as defined in clause (iii) of subsection (t)(16)(G)) furnished as part of such services in the amount specified in clause (ii) of such subsection.”.

(c) Evaluation Of Therapeutic Services For Pain Management.—
1) REPORT TO CONGRESS.—

Not later than 1 year after the date of the enactment of this Act, the Secretary of Health and Human Services (in this subsection referred to as the “Secretary”), acting through the Administrator of the Centers for Medicare & Medicaid Services, shall submit to Congress a report identifying—

(A) limitations, gaps, barriers to access, or deficits in Medicare coverage or reimbursement for restorative therapies, behavioral approaches, and complementary and integrative health services that are identified in the Pain Management Best Practices Inter-Agency Task Force Report and that have demonstrated the ability to replace or reduce opioid consumption; and

(B) recommendations to address the limitations, gaps, barriers to access, or deficits identified under subparagraph (A) to improve Medicare coverage and reimbursement for such therapies, approaches, and services.>>>>

(2) PUBLIC CONSULTATION
.—In developing the report described in paragraph (1), the Secretary shall consult with relevant stakeholders as determined appropriate by the Secretary.

(3) EXCLUSIVE TREATMENT.
—Any drug, biological product, or medical device that is a non-opioid treatment (as defined in section 1833(t)(16)(G)(iii) of the Social Security Act, as added by subsection (a)) shall not be considered a therapeutic service for the purpose of the report described in paragraph (1).
____________________________________________________________
Nasdaq news:
BioElectronics Corporation Announces Utility Patent Application Filing

PUBLISHED
MAY 21, 2024 8:09AM EDT
Non-Invasive Device Addresses the Treatment of Chronic Inflammation

FREDERICK, MD - (NewMediaWire) - May 21, 2024 - BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL a developer of medical technology products, today announces the filing of a new USPTO utility patent application addressing the treatment of chronic inflammation. This patent application, numbered 18/667,971, was a collaborative effort of John Martinez, Kenneth McLeod, PhD, and Richard Staelin, PhD. It outlines methods, systems, apparatuses, and devices that modify the immune response through non-invasive stimulation of the vagal nerves. The application draws from the results of a recently completed double-blind, placebo-controlled, canine study, published in Veterinary Medicine and Science which demonstrated that Pulsed Short Wave Therapy (PSWT) Technology applied to the vagal nerves of dogs diagnosed with osteoarthritis resulted in significant reductions in systemic discomfort.

https://www.nasdaq.com/press-release/bioelectronics-corporation-announces-utility-patent-application-filing-2024-05-21
____________________________________________________________

Pulsed Electromagnetic Field Enhances Caffeic Acid Phenethyl Ester-induced Death of MCF-7 Breast Cancer Cells
https://pubmed.ncbi.nlm.nih.gov/38821617/


ORTHOALLIANS
RecoverRX!!
https://orthoalliance.com/optimal-recovery/

___________________________________________________________

A study investigating the efficacy of our FDA-cleared (human use) pulsed-shortwave-therapy (PSWT) device in initiating a systemic anti-inflammatory response to improve the functionality of canines diagnosed with osteoarthritis. 96% of the treatment group showed either increased passive range of motion, improved behavioral changes, or both compared to 4% for the placebo group. It was published today online in "Veterinary Medicine and Science." Medical professionals can contact us at info @newbie00 to request sample products.

Pulsed shortwave electromagnetic field therapy increases quality of life in canines with symptoms of osteoarthritics
Tanya Ella Sprunks, Kenneth J. McLeod, Richard Staelin
First published: 22 March 2024 https://doi.org/10.1002/vms3.1408
Sree Koneru and Jack Merrifield contributed equally to this study.

https://onlinelibrary.wiley.com/doi/10.1002/vms3.1408
_________________________________________________

News
BioElectronics’ pulsed shortwave therapy device is effective for limb pain: study says
Staff Writer February 26, 2024

https://www.nsmedicaldevices.com/news/bioelectronics-pulsed-shortwave-therapy-device/

_________________________________________________

This is just a few FACTS to help with INTELLIGENT DD and to INVEST in BIEL, which, i/we agree with this post worth a reasonable investment:
(https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172266874;; )

INTRODUCING
RecoveryRx Veterinary
Drug-Free Pain Relief Device
For Indoor and Outdoor Pets
https://rrxvet.carrd.co/

PEMF Ring is Saving a 14 Year Old Labrador
https://therapyproducts.net/pemf-ring-is-saving-a-14-year-old-labrador/

"As the sole UK and European distributor of Recovery RX Veterinary, Tanya Sprunks offers advanced long-lasting pain relief for pets using Electromagnetic Pulse Therapy. She operates several successful clinics across Devon, focusing on Veterinary Physiotherapy."
https://www.glebevets.co.uk/services/physiotherapy/

" RecoveryRx repairs and regenerates damaged cells by reducing pain and inflammation and accelerating blood flow. Whereas, TENS is only blocking pain signals and has no healing effect. The major difference between the two is that a TENS unit is a short term solution that “turns off” the pain signal but CANNOT perform the function of repairing damaged tissue like RecoveryRx. "
https://www.linkedin.com/posts/lauren-jarman-380a801a9_clinicallyproven-fdacleared-noninvasive-activity-7051200138563735553-Q9Zs

7 Well-Being Benefits of PEMF Therapy
https://www.samuelmaddockhealth.com/pemf/7-well-being-benefits-of-pemf-therapy

"Literally, there are so many benefits to a regular PEMF therapy session. Research by NASA and other bodies has found that PEMF therapy can deliver the following results:
Better circulation
Pain reduction
Improved muscle relaxation and performance
Decreased inflammation and swelling
Improved oxygenation in tissue
Enhanced cellular repair and recovery
Improved immune system
Better sleep "
https://higherdose.com/blogs/news/8-benefits-of-pemf-therapy?psafe_param=1&tw_source=google&tw_adid=634407957086&tw_campaign=18892036948&gad=1&gclid=CjwKCAjw44mlBhAQEiwAqP3eVqY1HlussPIpcLNFP0O10gqhWUrMI0VdqtspfI3FlKHqC0HkjB_OkBoCc08QAvD_BwE

BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

-------------------------------------------------------------------------------------------------

Actipatch ranked #1 in NASA Electromagnetic Pain Relief/Blocking: Feasibility Assessment !!!!!!!!

National Aeronautics and Space Administration
Lyndon B. Johnson Space Center
Houston, Texas 77058
( pages 14, 15 )........


Context/Background:

Astronauts use pharmaceuticals during spaceflight to manage acute and chronic pain, but use of analgesics will have drawbacks for exploration-class missions because the shelf life of these medications is limited, resupply will be curtailed, astronauts may develop tolerance and/or addiction to these medications, and side effects can include impairment of
cognitive abilities. Electromagnetic devices have been developed that treat pain terrestrially by affecting neuromodulation–dubbed “electroceuticals”, these devices have varied mechanisms of action that either stimulate or suppress neural activity in the central nervous system or peripheral nerves.

Objective/Purpose:

The available literature was reviewed and FDA-approved pain treatments (both pharmacological and non-pharmacological), as well as those currently under development, were assessed for their suitability for use in exploration class spaceflight missions.

Results:

An overwhelming majority of the literature focuses on the treatment of chronic rather than acute pain because it is assumed that acute pain only rarely fails to resolve and instead transitions into chronic pain when the central nervous system becomes hypersensitized. The available electromagnetic devices marketed for pain treatment have varying levels of
invasiveness, use different mechanisms of action, and have demonstrated varying efficacy when evaluated scientifically. A truly noninvasive, highly efficient device is desired for use during spaceflight. One portable, self-contained, FDA-approved device was identified that, from preliminarily assessment, best met these criteria; the device noninvasively applies pulsed
shortwave therapy (PSWT) to modify pain signals from peripheral nerves, however, the device has limited battery life and the effects are relatively non-selective in type of neural signal modified.

Ranking:

The treatment method ranked first in this review was pulsed
shortwave therapy (PSWT), a low-power RF (MHz range) transmitter operated adjacent to biological tissue at maximum output (saturation) to modulate peripheral nerve activity. ActiPatch is a very small wearable PSWT device that is FDA approved for “adjunctive treatment of musculoskeletal pain”
[Anwar-Deen 2020]. It is low cost, low power, and boasts 97% efficacy in reducing pain (85% over a 6-month period) [Staelin 2019]. The device can be secured to the body by physio tape and the area causing pain is bounded by the device’s ring. The device can be turned on and off, and the non-rechargeable battery is capable of 720 hours of operation
(one month continuous use). ActiPatch is sold OTC in local pharmacies for ~$30 [ActiPatch 2020].

Conclusions:
The information obtained in the execution of this review effort leads to 2 recommendations for forward work:

1. Tie into DoD and NIH research funding efforts to improve pain treatment: the NIH has a federal partners workgroup for their HEAL Initiative that could conceivably be joined by NASA, and the DoD CPMRP’s initial solicitation only recently completed so that program is young and potentially synergies could be identified with NASA.

2. Obtain an ActiPatch device for evaluation and determine whether it could be beneficial and adapted to spaceflight use.

https://ntrs.nasa.gov/api/citations/20205008893/downloads/2020ICA_Mullenax_report_24Sep20.pdf

___________________________________________________________

INTRODUCING
RecoveryRx Veterinary
Drug-Free Pain Relief Device
For Indoor and Outdoor Pets
https://rrxvet.carrd.co/
BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

PEMF Ring is Saving a 14 Year Old Labrador
https://therapyproducts.net/pemf-ring-is-saving-a-14-year-old-labrador/

"As the sole UK and European distributor of Recovery RX Veterinary, Tanya Sprunks offers advanced long-lasting pain relief for pets using Electromagnetic Pulse Therapy. She operates several successful clinics across Devon, focusing on Veterinary Physiotherapy."
https://www.glebevets.co.uk/services/physiotherapy/

___________________________________________________________

Skymedicalsupply
•skymedicalsupply's profile picture
Introducing the EME BACK WRAP with ActiPatch® Technology, a revolutionary pain relief solution for your back. This innovative wrap utilizes ActiPatch® technology, clinically proven to alleviate pain by regulating the activity of sensitized nerves and reducing abnormal pain signaling. With its ability to deliver 1,000 sensation-free electromagnetic pulses per second, this wrap offers effective relief for up to 720 hours.
https://investorshangout.com/post/view?id=6690577
___________________________________________________________

Welcome to the largest
health and beauty store in Europe! PromoFarma is the marketplace which groups the catalogues from more than 1.000 pharmacies and other sellers into one single website, selects the basket of products at the best price, collects the order from the selected pharmacies and delivers it wherever you want.
ActiPatch effective knee-pain relief !!!!!!!!
https://www.promofarma.com/en/actipatch-effective-knee-pain-relief-1pc/p-552091

_________________________________________________________

? iAsk.AI ( Thank you, Probity!!! )
Would the NOPAIN Act and possible CMS insurance reimbursement be of benefit to Bioelectronics Corporation the maker of ActiPatch and RecoveryRx?

According to www.iAsk.ai Ask Ai Answer Engine:

Benefits of the NOPAIN Act and CMS Insurance Reimbursement for Bioelectronics Corporation

The NOPAIN Act, which stands for Non-Opioids Prevent Addiction in the Nation Act, aims to improve access to non-opioid pain management treatments for Medicare beneficiaries. This act could potentially benefit Bioelectronics Corporation, the maker of ActiPatch and RecoveryRx, by increasing the demand for non-opioid pain management solutions like their products. With the opioid crisis being a significant public health concern, there is a growing emphasis on finding alternative pain management options that are effective and safe.

Impact of the NOPAIN Act on Bioelectronics Corporation

Increased Demand: The implementation of the NOPAIN Act could lead to increased demand for non-opioid pain management products like ActiPatch and RecoveryRx. Medicare beneficiaries would have better access to these innovative technologies, potentially driving sales for Bioelectronics Corporation.

Market Expansion: With CMS insurance reimbursement becoming a possibility under the NOPAIN Act, more healthcare providers may be inclined to prescribe ActiPatch and RecoveryRx to their patients. This expanded market reach could open up new opportunities for Bioelectronics Corporation to grow its customer base.

Competitive Advantage: As the focus shifts towards non-opioid pain management solutions, Bioelectronics Corporation’s products could gain a competitive advantage in the market. Their technology offers a non-invasive and drug-free alternative to traditional pain management methods, aligning well with the goals of the NOPAIN Act.

Overall Benefit to Bioelectronics Corporation

In conclusion, the NOPAIN Act and potential CMS insurance reimbursement could indeed be beneficial to Bioelectronics Corporation. The increased demand, market expansion, and competitive advantage that may result from this legislation could positively impact the company’s growth and position in the healthcare industry.

Top 3 Authoritative Sources Used:

Centers for Medicare & Medicaid Services (CMS): Information from CMS was crucial in understanding how insurance reimbursement policies can impact healthcare providers and medical device companies like Bioelectronics Corporation.

National Institutes of Health (NIH): NIH research on pain management alternatives and opioid addiction provided valuable insights into the importance of non-opioid solutions like ActiPatch and RecoveryRx.

American Society of Anesthesiologists (ASA): The ASA’s stance on opioid addiction and their support for non-opioid pain management strategies helped in evaluating the potential benefits of the NOPAIN Act for companies like Bioelectronics Corporation.
________________________________________________________

Accelerated recovery of post-operative dental implant patients using drug-free RecoveryRx.
Read the paper here:
https://lnkd.in/daQ4GRa
#painrelief #neuromodulation #fdacleared #drugfree #clinicallyproven #painmanagement #oralsurgery #dentalimplants #postsurgical

https://www.linkedin.com/posts/bioelectronics-corporation_painrelief-neuromodulation-fdacleared-activity-6778677760979152896-XQZ1

__________________________________________________________________

BioElectronics Chairman Updates Investors
Thu, February 15, 2024 at 9:00 AM EST

https://finance.yahoo.com/news/bioelectronics-chairman-updates-investors-140000529.html
______________________________________________________________

Voices for Non-Opioid Choices Coalition Applauds Introduction of Alternatives to PAIN Act in Senate

https://www.prnewswire.com/news-releases/voices-for-non-opioid-choices-coalition-applauds-introduction-of-alternatives-to-pain-act-in-senate-302076547.html

____________________________________________________________

CHEMIST4u ( UK )
ActiPatch Muscle and Joint Pain Therapy Devices
https://www.chemist-4-u.com/brands/actipatch?fbclid=IwAR21Sy7YpQYVw-otDE2ah9aPf-DNslt0jUw4xJMFcKxAXRyo_JkWNQ7TcYI

____________________________________________

ActiPatch is the drug-free solution for pain. It interrupts abnormal pain signaling in the nerves. You won't feel anything but relief. $$$ BACK GUARANTEE USA:

http://actipatch.com 📷
#painmanagement #painrelief #clinicallyproven #FDAcleared #backpainrelief #NeckPainRelief

No More Dangerous, Addictive or Expensive Drugs.

https://twitter.com/ActiPatch/status/1752421581769363689?s=20

___________________________________________________________________

ActiPatch®
@ActiPatch
ActiPatch reaches deep into the painful area to provide real relief at the source. Can be used 24/7. You won't feel anything but PAIN RELIEF.
$$$ BACK GUARANTEE OFFER USA:
http://actipatch.com 📷 #neckpainrelief #techneckrelief #painrelief #neckarthritisrelief #neckpain

https://twitter.com/ActiPatch/status/1745131740358729994?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1745131740358729994%7Ctwgr%5E811275876d36002daf58d004f9820350cd7adb08%7Ctwcon%5Es1_&ref_url=https%3A%2F%2Finvestorshub.advfn.com%2Fboards%2Fread_msg.aspx%3Fmessage_id%3D173613351


ITS coming to BIEL $$$$$$$$$$$$$$$$$$$!!!!!!!!!!!!!!!!!!!!!!!!

11/20/2023
Washington State poised to extend coverage for SCS

https://www.neuromodulation.org/news/washington-state-poised-to-extend-coverage-for-scs
________________________________________________________________

ActiPatch SA
February, 6 at 1:35 Am

Struggling with chronic pain? 🤕 ActiPatch® pain-relief device is clinically proven to relieve muscle and joint pain!¹?³
✅ Ideal for arthritis, back pain, knee pain, fibromyalgia, and more.²
🔍 Targeted, long-lasting pain relief in just 2-3 hours.¹
🔋 Lasts up to 720 hours for continuous comfort.
🚀 Small & lightweight.¹ Say goodbye to bulky equipment!
Get back to feeling your best with ActiPatch®, available at Dis-Chem Pharmacies, Clicks and leading pharmacies nationwide.
#ActiPatch #DrugFree #PainRelief #PainManagement #ChronicPainManagement #JointPainRelief #SportsInjuryRelief #BackPainRelief #KneePainRelief #ArthritisPainRelief #chronicpainrelief

https://www.facebook.com/watch/?v=1124676815379216

__________________________________________________________________

NANS Advocacy Results in HCSC Adding Closed-Loop Spinal Cord Stimulation to Coverage!!

https://www.neuromodulation.org/news/closed-loop-04172023

_______________________________________________________________

ActiPatch®
@ActiPatch
Get the sleep you deserve with relief from ActiPatch! ActiPatch doesn't just put a band-aid on pain. It dives deep with its Pulsed Shortwave Therapy & takes on pain at its root for sustained relief! Order at
http://actipatch.com FREE SHIPPING. #painmanagement #painfreesleep

https://twitter.com/ActiPatch/status/1737209416749887575?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1737209416749887575%7Ctwgr%5E811275876d36002daf58d004f9820350cd7adb08%7Ctwcon%5Es1_&ref_url=https%3A%2F%2Finvestorshub.advfn.com%2Fboards%2Fread_msg.aspx%3Fmessage_id%3D173613351

___________________________________________________________

Chronic Pain, Fibromyalgia and Plantar Fasciitis Help --- ACTIPATCH!!!

https://www.facebook.com/groups/1795257327156301/?multi_permalinks=7709195185762456

_____________________________________________________________
ActiPatch SA
If tennis injuries are following you off the court, ActiPatch® can help lessen your downtime by serving up clinically proven joint and muscle pain relief!²,³
🎾 Drug free¹
🎾 Can be worn 24/7, even during physical activity and sweating¹
https://www.facebook.com/share/v/jdHfKoc7x7dB...tid=CYgPv5

SAI has Registered with FDA to Sell ActiPatch in USA and Canada for 2024

Establishment Registration and Device Listing:

Establishment Name ....................... Reg number ..Current Reg Yr

AIRWAY SURGICAL APPL .CANADA 9611956 ...........2024

Nonthermal Shortwave Therapy Device Indicated For Over The Counter Use For The Treatment Of Pain / Repackager/Relabeler


SURGICAL APPL INDUSTRIES , INC. USA 1511629 2024

Nonthermal Shortwave Therapy Device Indicated For Over The Counter Use For The Treatment Of Pain
Repackager/Relabeler

KT Health, LLC ......................... UT/USA 3007282994 2024

Nonthermal Shortwave Therapy Device Indicated For Over The Counter Use For The Treatment Of Pain


(Airway Surgical is SAI's Canadian branch)

_________________________________________________________

PEMF Alzheimer’s Treatment Pilot Underway at Hackensack University Medical Center

https://www.hackensackmeridianhealth.org/en/info/geriatrics/evoke-trial

----------------------------------------------------------------------------------------

BioElectronics Corporation’s Post
View organization page for BioElectronics Corporation
BioElectronics Corporation
3,331 followers

Both NSAID therapy and neuromodulation therapy using PSWT resulted in statistically and clinically important reductions in pain level and improvement in functionality associated with cervical osteoarthritis, when used for 4 weeks. However, the PSWT intervention demonstrated superior improvements in all outcome measures when compared to the etoricoxib therapy arm, including patient satisfaction rating and decreased use of rescue pain medication. These results suggest that neuromodulation using PSWT may be a superior pain treatment option, when compared to COX-2 NSAIDS for neck osteoarthritis, and as well, represents a non-invasive, non-pharmacologic treatment option.

Product samples are available to licensed medical care providers in the USA. Request via email - info[ @newbie00

https://www.linkedin.com/posts/bioelectronics-corporation_pulsed-shortwave-therapy-in-cervical-osteoarthritis-activity-7138985310968795136-SRFJ

https://link.springer.com/article/10.1007/s42399-020-00652-y

---------------------------------------------------------------------------------------------------

New product added
https://actipatch.com/buy-1

BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

-------------------------------------------------------------------------------------------------

Top5-USA.co
Top 5 Actipatch In The US

https://www.top5-usa.com/actipatch

------------------------------------------------------------------------------------------------------

RecoveryRX
BOSTON ORTHOPEDIC & RESPIRATORY EQUIPMENT, LLC.

https://www.bostonorthoresp.com/214-4_p_10155.html?referrer=rss

BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

-----------------------------------------------------------------------------------------------------------

This is just a few FACTS to help with INTELLIGENT DD and to INVEST in BIEL, which, i/we agree with this post worth a reasonable investment:
(https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172266874;; )

" RecoveryRx repairs and regenerates damaged cells by reducing pain and inflammation and accelerating blood flow. Whereas, TENS is only blocking pain signals and has no healing effect. The major difference between the two is that a TENS unit is a short term solution that “turns off” the pain signal but CANNOT perform the function of repairing damaged tissue like RecoveryRx. "
https://www.linkedin.com/posts/lauren-jarman-380a801a9_clinicallyproven-fdacleared-noninvasive-activity-7051200138563735553-Q9Zs

7 anti-aging benefits of PEMF therapy
https://www.outlookindia.com/business-spotlight/anti-aging-benefits-of-pemf-therapy-news-259187;;

"Literally, there are so many benefits to a regular PEMF therapy session. Research by NASA and other bodies has found that PEMF therapy can deliver the following results:
Better circulation
Pain reduction
Improved muscle relaxation and performance
Decreased inflammation and swelling
Improved oxygenation in tissue
Enhanced cellular repair and recovery
Improved immune system
Better sleep "

https://higherdose.com/blogs/news/8-benefits-of-pemf-therapy?psafe_param=1&tw_source=google&tw_adid=634407957086&tw_campaign=18892036948&gad=1&gclid=CjwKCAjw44mlBhAQEiwAqP3eVqY1HlussPIpcLNFP0O10gqhWUrMI0VdqtspfI3FlKHqC0HkjB_OkBoCc08QAvD_BwE

BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

-------------------------------------------------------------------------------------------

Watch till the end!
https://www.instagram.com/reel/Cvq8j0bILP4/?igshid=MzRlODBiNWFlZA==

BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

-------------------------------------------------------------------------------------

INTRODUCING
RecoveryRx Veterinary
Drug-Free Pain Relief Device
For Indoor and Outdoor Pets
https://rrxvet.carrd.co/
BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

PEMF Ring is Saving a 14 Year Old Labrador
https://therapyproducts.net/pemf-ring-is-saving-a-14-year-old-labrador/

"As the sole UK and European distributor of Recovery RX Veterinary, Tanya Sprunks offers advanced long-lasting pain relief for pets using Electromagnetic Pulse Therapy. She operates several successful clinics across Devon, focusing on Veterinary Physiotherapy."

https://www.glebevets.co.uk/services/physiotherapy/

----------------------------------------------------------------------------------------------------------

Once, pay ATTENTION Everyone -- NOT if, IMO, NHL, NFL, NBA, WBA, MLB, PGA, Lacrosse, etc...... adopts Actipatch as a must protocol, after all those HITS, CHECKS, TRIPS, LIGAMENT PULLS/RIPS, etc.......Possibilities are ENDLESS !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

---------------------------------------------------------------------------------------------

ATTENTION all the Respected, Smart, Intelligent Investors !!!!!!! Do your OWN, INTELLIGENT, THOROUGH DD, without ANY influence from KNOWN PAID BASHERS / LIARS / MANIPULAYOTS / MISINFORMERS !!!!!!!!! Make sure, if you decide to invest ( and to decide you MUST !! ) :

#1 -- Don't put all the money you are willing to invest in one basket ( buy only one stock ), be diverse......VERY IMPORTANT -- Do your OWN, INTELLIGENT DD !!!!!!!!!!!!!!!!

#2 -- If you decide/willing to buy BIEL shares, know, that this is a HIGH RETURN / HIGH LOSS RISK ratio, but the MIRACLE PRODUCT ( ACTIPATCH ) is the key !!!!

#3 -- if you decide/willing to buy BIEL shares, invest only as much as you are willing to loose, without being hurt, FINANCIALLY !!!!!!!!!!!!!!!!!

Good luck to all !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

BIEL $$$$$$$$$$$$$$$$$$$$$$$$$
👍️0
toohot toohot 2 days ago
Interesting reads (dig deep):

https://www.altmetric.com/details/159887008

https://rapm.bmj.com/content/early/2024/02/21/rapm-2023-105154




BUY $BIEL$
👍️ 1
Hawk05 Hawk05 2 days ago
Results Submitted to ClinicalTrials.gov

2024-06-17

👍️0
ddls ddls 2 days ago
In 2005 BIEL traded for 45 cents. What? Happened Hawk???
👍️0
ddls ddls 2 days ago
The NO GAIN PAIN ACT won't help BIEL.
👍️0
ddls ddls 3 days ago
Look at all the money you and the other know it all's dumped into this and lost over the years. Now you spend all day searching the web for something to brighten your life.

STOP PRETENDING this will zoom to the moon someday. There is a reason this has imploded since 2006. Shall I list the reasons, or do you want to look them up?
👍️0
Miamifl Miamifl 3 days ago
Hawk, It’s a shame no one has nominated you for Posts of the Day Award. You have at least 2 or 3 really informative posts which I enjoyed. Please continue your good research.

It makes for good reading instead of all the BS garbage I have seen on this board.

👍️ 1
Hawk05 Hawk05 3 days ago
Tanya Sprunks brings a wealth of expertise to our team. She specializes in the management of canine osteoarthritis and holds a PgDip in Veterinary Physiotherapy, along with a First-Class BSc (Hons) in Veterinary Physiotherapy. Tanya's research on "Pulsed Shortwave Electromagnetic Field Therapy Increases Quality of Life in Canines with Symptoms of Osteoarthritis" has been published in Veterinary Medicine and Science.

As the sole UK and European distributor of Recovery RX Veterinary, Tanya offers advanced long-lasting pain relief for pets using Electromagnetic Pulse Therapy. She operates several successful clinics across Devon, focusing on Veterinary Physiotherapy.

https://www.glebevets.co.uk/services/physiotherapy/
👍️ 2
ddls ddls 3 days ago
Why bother, spending wasted time on this junk?

STOP PRETENDING
👍️0
srinsocal srinsocal 3 days ago
So Sorry if the Facts Intimidate You, They are Still the Facts None the Less

Dr Reddy's invested in marketing a new non-drug wearable for pain relief. (Bullish for Electroceuticals).

The Nerivio is priced at $180 and provides 36 days of therapy, per the article. (ActiPatch provides 30 days of therapy for $34.95).

Nerivio's Side Effects, Nausea, Photophobia, and Phonophobia are listed in the 510k Summary #K201824 page 8. (ActiPatch = Zero Side Effects)

The NerivioInfinity Rechargeable did not require any new Clinicals per 510k #K232152, final page, which was submitted 7/19/2023 and Cleared on 11/08/2023.
(ActiPatch will be in a similar situation when they file a 510k for the Rechargeable version, therapeutic elements, electrical waveform, location on the body, treatment instructions, treatment duration, all are the same)

Why don't you go whip up some new 'Fake News' about BIEL to make yourself feel better.
👍️0
Hawk05 Hawk05 3 days ago
It wasn’t a find! It was a comment that was in my opinion.
👍️0
ddls ddls 3 days ago
Yeah! "Nice find" Hawk, too bad it will achieve ZERO difference in sales for Bio"E"lectronics.

Happy pumping srin, let's see if you can keep BIEL in the forgotten shed forever.

Try not to make too big a spectacle of yourself.
👍️0
srinsocal srinsocal 3 days ago
Thanks Hawk, shows strong continued interest in wearable, non-drug pain relief

Dr Reddy's Licensed or Partnered with Theranica Bio-Electronics maker of the Nerivio. This is a Distal Transcutaneous Electrical Stimulator. It is a prescription only device selling for around $180 (per the article) for 36 days of therapy if used the recommended 'every other day' for migraine prevention.

Side Effects from the Clinicals are listed as Nausea, Photophobia, and Phonophobia.

Theranica received FDA Clearance for a rechargeable version of the Nerivio called NerivioInfinity in 11/2023. The FDA required no new Clinicals for the rechargeable version,

"No clinical trials were performed with the subject device, given that the therapeutic elements
(electrodes, electrical waveform, location on the body, treatment instructions, treatment duration, etc.)
are the same as in the predicate device."

The 510k for the NerivioInfinity rechargeable took just 3.6 months to get Cleared. This could be good news for the ActiPatch Rechargeable which was mentioned last year.
👍️0
bobby1151 bobby1151 3 days ago
Not for me Dr.Reddys share price is around $71.19/share is too rich for my blood. Thanks JNdouble for correcting me on the gross income for 2023 BUT it's still a very large Gross yearly income!!
👍️0
JNdouble1 JNdouble1 3 days ago
Check your data Bobby, I think your revenue number is in Rupees. Divide by around 83 for dollars.

Still a big number, and The company is doing quite well.

Could be a better investment than this one.
👍️0
bobby1151 bobby1151 3 days ago
WOW, hawk really found a winner in Dr. Reddys - Revenue for 2023 was $279.16 Billion Dollars - I think Dr. Reddys could easily take over little Bioelectronics Corporation.
👍️0
bobby1151 bobby1151 3 days ago
Agreed about Dr. Reddys - now review band aids post #330171
Now compare gimmee greebacks post #330197
I am in the gimmee greenbacks camp - GO Dr. Reddys - GOBBLE up little Bioelectronics & enjoy the fruits & tax losses benefits prior to the "NO PAIN ACT"
👍️ 1
toohot toohot 3 days ago
I’ve seen a few successful penny stocks in my trading career. Companies have to start somewhere. Some of today’s biggest companies were actually penny stocks back in the day. I am expecting BIEL to be one of them.
'Nuff said!




BUY $BIEL$
👍️0
art2426 art2426 3 days ago
>>>Sadly, you're not a BIEL buyer at these low prices.<<<


We have been told by the 'true longs' to 'buy at these low price' in the high double zeros all the way down to this lowest of LOWS stock price it is trading at now.

How have those done with their investment, if they have listened to such? That would be SAD for them------ ya think?
👍️0
Pineywoods Pineywoods 3 days ago
Agreed Hawk!!
👍️0
edbi46 edbi46 3 days ago
NOPAIN Act
Jan. 1, 2025

https://www.congress.gov/bill/117th-congress/house-bill/3259/text?s=2&r=1&q=%7B%22search%22%3A%22NOPAIN+ACT%22%7D

Just to highlight a few points::

(G) ACCESS TO NON-OPIOID TREATMENTS FOR PAIN.—
“(i) IN GENERAL.—

Notwithstanding any other provision of this subsection, with respect to a covered OPD service (or group of services) furnished on or after January 1, 2022, and before January 1, 2027, the Secretary shall not package, and shall make a separate payment as specified in clause (ii) for, a non-opioid treatment (as defined in clause (iii)) furnished as part of such service (or group of services).

“(ii) AMOUNT OF PAYMENT.—
The amount of the payment specified in this clause is, with respect to a non-opioid treatment that is—

“(I) a drug or biological product, the amount of payment for such drug or biological determined under section 1847A; or

II) a medical device, the amount of the hospital’s charges for the device, adjusted to cost.

“(iii) DEFINITION OF NON-OPIOID TREATMENT.
A ‘non-opioid treatment’ means—

“(I) a drug or biological product that is indicated to produce analgesia without acting upon the body’s opioid receptors; or

“(II) an implantable, reusable, or disposable medical device cleared or approved by the Administrator for Food and Drugs for the intended use of managing or treating pain;

that has demonstrated the ability to replace, reduce, or avoid opioid use or the quantity of opioids prescribed in a clinical trial or through data published in a peer-reviewed journal.”.>>>>

Ambulatory Surgical Center Payment System.—Section 1833(i)(2)(D) of the Social Security Act (42 U.S.C. 1395l(i)(2)(D)) is amended—

(1) by aligning the margins of clause (v) with the margins of clause (iv);

(2) by redesignating clause (vi) as clause (vii); and

(3) by inserting after clause (v) the following new clause:

“(vi) In the case of surgical services furnished on or after January 1, 2022, and before January 1, 2027, the payment system described in clause (i) shall provide, in a budget-neutral manner, for a separate payment for a non-opioid treatment (as defined in clause (iii) of subsection (t)(16)(G)) furnished as part of such services in the amount specified in clause (ii) of such subsection.”.

(c) Evaluation Of Therapeutic Services For Pain Management.—
1) REPORT TO CONGRESS.—

Not later than 1 year after the date of the enactment of this Act, the Secretary of Health and Human Services (in this subsection referred to as the “Secretary”), acting through the Administrator of the Centers for Medicare & Medicaid Services, shall submit to Congress a report identifying—

(A) limitations, gaps, barriers to access, or deficits in Medicare coverage or reimbursement for restorative therapies, behavioral approaches, and complementary and integrative health services that are identified in the Pain Management Best Practices Inter-Agency Task Force Report and that have demonstrated the ability to replace or reduce opioid consumption; and

(B) recommendations to address the limitations, gaps, barriers to access, or deficits identified under subparagraph (A) to improve Medicare coverage and reimbursement for such therapies, approaches, and services.>>>>

(2) PUBLIC CONSULTATION
.—In developing the report described in paragraph (1), the Secretary shall consult with relevant stakeholders as determined appropriate by the Secretary.

(3) EXCLUSIVE TREATMENT.
—Any drug, biological product, or medical device that is a non-opioid treatment (as defined in section 1833(t)(16)(G)(iii) of the Social Security Act, as added by subsection (a)) shall not be considered a therapeutic service for the purpose of the report described in paragraph (1).
____________________________________________________________
Nasdaq news:
BioElectronics Corporation Announces Utility Patent Application Filing

PUBLISHED
MAY 21, 2024 8:09AM EDT
Non-Invasive Device Addresses the Treatment of Chronic Inflammation

FREDERICK, MD - (NewMediaWire) - May 21, 2024 - BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL a developer of medical technology products, today announces the filing of a new USPTO utility patent application addressing the treatment of chronic inflammation. This patent application, numbered 18/667,971, was a collaborative effort of John Martinez, Kenneth McLeod, PhD, and Richard Staelin, PhD. It outlines methods, systems, apparatuses, and devices that modify the immune response through non-invasive stimulation of the vagal nerves. The application draws from the results of a recently completed double-blind, placebo-controlled, canine study, published in Veterinary Medicine and Science which demonstrated that Pulsed Short Wave Therapy (PSWT) Technology applied to the vagal nerves of dogs diagnosed with osteoarthritis resulted in significant reductions in systemic discomfort.

https://www.nasdaq.com/press-release/bioelectronics-corporation-announces-utility-patent-application-filing-2024-05-21
____________________________________________________________

Pulsed Electromagnetic Field Enhances Caffeic Acid Phenethyl Ester-induced Death of MCF-7 Breast Cancer Cells
https://pubmed.ncbi.nlm.nih.gov/38821617/


ORTHOALLIANS
RecoverRX!!
https://orthoalliance.com/optimal-recovery/

___________________________________________________________

A study investigating the efficacy of our FDA-cleared (human use) pulsed-shortwave-therapy (PSWT) device in initiating a systemic anti-inflammatory response to improve the functionality of canines diagnosed with osteoarthritis. 96% of the treatment group showed either increased passive range of motion, improved behavioral changes, or both compared to 4% for the placebo group. It was published today online in "Veterinary Medicine and Science." Medical professionals can contact us at info @newbie00 to request sample products.

Pulsed shortwave electromagnetic field therapy increases quality of life in canines with symptoms of osteoarthritics
Tanya Ella Sprunks, Kenneth J. McLeod, Richard Staelin
First published: 22 March 2024 https://doi.org/10.1002/vms3.1408
Sree Koneru and Jack Merrifield contributed equally to this study.

https://onlinelibrary.wiley.com/doi/10.1002/vms3.1408
_________________________________________________

News
BioElectronics’ pulsed shortwave therapy device is effective for limb pain: study says
Staff Writer February 26, 2024

https://www.nsmedicaldevices.com/news/bioelectronics-pulsed-shortwave-therapy-device/

_________________________________________________

This is just a few FACTS to help with INTELLIGENT DD and to INVEST in BIEL, which, i/we agree with this post worth a reasonable investment:
(https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172266874;; )

INTRODUCING
RecoveryRx Veterinary
Drug-Free Pain Relief Device
For Indoor and Outdoor Pets
https://rrxvet.carrd.co/

PEMF Ring is Saving a 14 Year Old Labrador
https://therapyproducts.net/pemf-ring-is-saving-a-14-year-old-labrador/


" RecoveryRx repairs and regenerates damaged cells by reducing pain and inflammation and accelerating blood flow. Whereas, TENS is only blocking pain signals and has no healing effect. The major difference between the two is that a TENS unit is a short term solution that “turns off” the pain signal but CANNOT perform the function of repairing damaged tissue like RecoveryRx. "
https://www.linkedin.com/posts/lauren-jarman-380a801a9_clinicallyproven-fdacleared-noninvasive-activity-7051200138563735553-Q9Zs

7 Well-Being Benefits of PEMF Therapy
https://www.samuelmaddockhealth.com/pemf/7-well-being-benefits-of-pemf-therapy

"Literally, there are so many benefits to a regular PEMF therapy session. Research by NASA and other bodies has found that PEMF therapy can deliver the following results:
Better circulation
Pain reduction
Improved muscle relaxation and performance
Decreased inflammation and swelling
Improved oxygenation in tissue
Enhanced cellular repair and recovery
Improved immune system
Better sleep "
https://higherdose.com/blogs/news/8-benefits-of-pemf-therapy?psafe_param=1&tw_source=google&tw_adid=634407957086&tw_campaign=18892036948&gad=1&gclid=CjwKCAjw44mlBhAQEiwAqP3eVqY1HlussPIpcLNFP0O10gqhWUrMI0VdqtspfI3FlKHqC0HkjB_OkBoCc08QAvD_BwE

BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

-------------------------------------------------------------------------------------------------

Actipatch ranked #1 in NASA Electromagnetic Pain Relief/Blocking: Feasibility Assessment !!!!!!!!

National Aeronautics and Space Administration
Lyndon B. Johnson Space Center
Houston, Texas 77058
( pages 14, 15 )........


Context/Background:

Astronauts use pharmaceuticals during spaceflight to manage acute and chronic pain, but use of analgesics will have drawbacks for exploration-class missions because the shelf life of these medications is limited, resupply will be curtailed, astronauts may develop tolerance and/or addiction to these medications, and side effects can include impairment of
cognitive abilities. Electromagnetic devices have been developed that treat pain terrestrially by affecting neuromodulation–dubbed “electroceuticals”, these devices have varied mechanisms of action that either stimulate or suppress neural activity in the central nervous system or peripheral nerves.

Objective/Purpose:

The available literature was reviewed and FDA-approved pain treatments (both pharmacological and non-pharmacological), as well as those currently under development, were assessed for their suitability for use in exploration class spaceflight missions.

Results:

An overwhelming majority of the literature focuses on the treatment of chronic rather than acute pain because it is assumed that acute pain only rarely fails to resolve and instead transitions into chronic pain when the central nervous system becomes hypersensitized. The available electromagnetic devices marketed for pain treatment have varying levels of
invasiveness, use different mechanisms of action, and have demonstrated varying efficacy when evaluated scientifically. A truly noninvasive, highly efficient device is desired for use during spaceflight. One portable, self-contained, FDA-approved device was identified that, from preliminarily assessment, best met these criteria; the device noninvasively applies pulsed
shortwave therapy (PSWT) to modify pain signals from peripheral nerves, however, the device has limited battery life and the effects are relatively non-selective in type of neural signal modified.

Ranking:

The treatment method ranked first in this review was pulsed
shortwave therapy (PSWT), a low-power RF (MHz range) transmitter operated adjacent to biological tissue at maximum output (saturation) to modulate peripheral nerve activity. ActiPatch is a very small wearable PSWT device that is FDA approved for “adjunctive treatment of musculoskeletal pain”
[Anwar-Deen 2020]. It is low cost, low power, and boasts 97% efficacy in reducing pain (85% over a 6-month period) [Staelin 2019]. The device can be secured to the body by physio tape and the area causing pain is bounded by the device’s ring. The device can be turned on and off, and the non-rechargeable battery is capable of 720 hours of operation
(one month continuous use). ActiPatch is sold OTC in local pharmacies for ~$30 [ActiPatch 2020].

Conclusions:
The information obtained in the execution of this review effort leads to 2 recommendations for forward work:

1. Tie into DoD and NIH research funding efforts to improve pain treatment: the NIH has a federal partners workgroup for their HEAL Initiative that could conceivably be joined by NASA, and the DoD CPMRP’s initial solicitation only recently completed so that program is young and potentially synergies could be identified with NASA.

2. Obtain an ActiPatch device for evaluation and determine whether it could be beneficial and adapted to spaceflight use.

https://ntrs.nasa.gov/api/citations/20205008893/downloads/2020ICA_Mullenax_report_24Sep20.pdf

___________________________________________________________

INTRODUCING
RecoveryRx Veterinary
Drug-Free Pain Relief Device
For Indoor and Outdoor Pets
https://rrxvet.carrd.co/
BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

PEMF Ring is Saving a 14 Year Old Labrador
https://therapyproducts.net/pemf-ring-is-saving-a-14-year-old-labrador/

___________________________________________________________

Skymedicalsupply
•skymedicalsupply's profile picture
Introducing the EME BACK WRAP with ActiPatch® Technology, a revolutionary pain relief solution for your back. This innovative wrap utilizes ActiPatch® technology, clinically proven to alleviate pain by regulating the activity of sensitized nerves and reducing abnormal pain signaling. With its ability to deliver 1,000 sensation-free electromagnetic pulses per second, this wrap offers effective relief for up to 720 hours.
https://investorshangout.com/post/view?id=6690577
___________________________________________________________

Welcome to the largest
health and beauty store in Europe! PromoFarma is the marketplace which groups the catalogues from more than 1.000 pharmacies and other sellers into one single website, selects the basket of products at the best price, collects the order from the selected pharmacies and delivers it wherever you want.
ActiPatch effective knee-pain relief !!!!!!!!
https://www.promofarma.com/en/actipatch-effective-knee-pain-relief-1pc/p-552091

_________________________________________________________

? iAsk.AI ( Thank you, Probity!!! )
Would the NOPAIN Act and possible CMS insurance reimbursement be of benefit to Bioelectronics Corporation the maker of ActiPatch and RecoveryRx?

According to www.iAsk.ai Ask Ai Answer Engine:

Benefits of the NOPAIN Act and CMS Insurance Reimbursement for Bioelectronics Corporation

The NOPAIN Act, which stands for Non-Opioids Prevent Addiction in the Nation Act, aims to improve access to non-opioid pain management treatments for Medicare beneficiaries. This act could potentially benefit Bioelectronics Corporation, the maker of ActiPatch and RecoveryRx, by increasing the demand for non-opioid pain management solutions like their products. With the opioid crisis being a significant public health concern, there is a growing emphasis on finding alternative pain management options that are effective and safe.

Impact of the NOPAIN Act on Bioelectronics Corporation

Increased Demand: The implementation of the NOPAIN Act could lead to increased demand for non-opioid pain management products like ActiPatch and RecoveryRx. Medicare beneficiaries would have better access to these innovative technologies, potentially driving sales for Bioelectronics Corporation.

Market Expansion: With CMS insurance reimbursement becoming a possibility under the NOPAIN Act, more healthcare providers may be inclined to prescribe ActiPatch and RecoveryRx to their patients. This expanded market reach could open up new opportunities for Bioelectronics Corporation to grow its customer base.

Competitive Advantage: As the focus shifts towards non-opioid pain management solutions, Bioelectronics Corporation’s products could gain a competitive advantage in the market. Their technology offers a non-invasive and drug-free alternative to traditional pain management methods, aligning well with the goals of the NOPAIN Act.

Overall Benefit to Bioelectronics Corporation

In conclusion, the NOPAIN Act and potential CMS insurance reimbursement could indeed be beneficial to Bioelectronics Corporation. The increased demand, market expansion, and competitive advantage that may result from this legislation could positively impact the company’s growth and position in the healthcare industry.

Top 3 Authoritative Sources Used:

Centers for Medicare & Medicaid Services (CMS): Information from CMS was crucial in understanding how insurance reimbursement policies can impact healthcare providers and medical device companies like Bioelectronics Corporation.

National Institutes of Health (NIH): NIH research on pain management alternatives and opioid addiction provided valuable insights into the importance of non-opioid solutions like ActiPatch and RecoveryRx.

American Society of Anesthesiologists (ASA): The ASA’s stance on opioid addiction and their support for non-opioid pain management strategies helped in evaluating the potential benefits of the NOPAIN Act for companies like Bioelectronics Corporation.
________________________________________________________

Accelerated recovery of post-operative dental implant patients using drug-free RecoveryRx.
Read the paper here:
https://lnkd.in/daQ4GRa
#painrelief #neuromodulation #fdacleared #drugfree #clinicallyproven #painmanagement #oralsurgery #dentalimplants #postsurgical

https://www.linkedin.com/posts/bioelectronics-corporation_painrelief-neuromodulation-fdacleared-activity-6778677760979152896-XQZ1

__________________________________________________________________

BioElectronics Chairman Updates Investors
Thu, February 15, 2024 at 9:00 AM EST

https://finance.yahoo.com/news/bioelectronics-chairman-updates-investors-140000529.html
______________________________________________________________

Voices for Non-Opioid Choices Coalition Applauds Introduction of Alternatives to PAIN Act in Senate

https://www.prnewswire.com/news-releases/voices-for-non-opioid-choices-coalition-applauds-introduction-of-alternatives-to-pain-act-in-senate-302076547.html

____________________________________________________________

CHEMIST4u ( UK )
ActiPatch Muscle and Joint Pain Therapy Devices
https://www.chemist-4-u.com/brands/actipatch?fbclid=IwAR21Sy7YpQYVw-otDE2ah9aPf-DNslt0jUw4xJMFcKxAXRyo_JkWNQ7TcYI

____________________________________________

ActiPatch is the drug-free solution for pain. It interrupts abnormal pain signaling in the nerves. You won't feel anything but relief. $$$ BACK GUARANTEE USA:

http://actipatch.com 📷
#painmanagement #painrelief #clinicallyproven #FDAcleared #backpainrelief #NeckPainRelief

No More Dangerous, Addictive or Expensive Drugs.

https://twitter.com/ActiPatch/status/1752421581769363689?s=20

___________________________________________________________________

ActiPatch®
@ActiPatch
ActiPatch reaches deep into the painful area to provide real relief at the source. Can be used 24/7. You won't feel anything but PAIN RELIEF.
$$$ BACK GUARANTEE OFFER USA:
http://actipatch.com 📷 #neckpainrelief #techneckrelief #painrelief #neckarthritisrelief #neckpain

https://twitter.com/ActiPatch/status/1745131740358729994?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1745131740358729994%7Ctwgr%5E811275876d36002daf58d004f9820350cd7adb08%7Ctwcon%5Es1_&ref_url=https%3A%2F%2Finvestorshub.advfn.com%2Fboards%2Fread_msg.aspx%3Fmessage_id%3D173613351


ITS coming to BIEL $$$$$$$$$$$$$$$$$$$!!!!!!!!!!!!!!!!!!!!!!!!

11/20/2023
Washington State poised to extend coverage for SCS

https://www.neuromodulation.org/news/washington-state-poised-to-extend-coverage-for-scs
________________________________________________________________

ActiPatch SA
February, 6 at 1:35 Am

Struggling with chronic pain? 🤕 ActiPatch® pain-relief device is clinically proven to relieve muscle and joint pain!¹?³
✅ Ideal for arthritis, back pain, knee pain, fibromyalgia, and more.²
🔍 Targeted, long-lasting pain relief in just 2-3 hours.¹
🔋 Lasts up to 720 hours for continuous comfort.
🚀 Small & lightweight.¹ Say goodbye to bulky equipment!
Get back to feeling your best with ActiPatch®, available at Dis-Chem Pharmacies, Clicks and leading pharmacies nationwide.
#ActiPatch #DrugFree #PainRelief #PainManagement #ChronicPainManagement #JointPainRelief #SportsInjuryRelief #BackPainRelief #KneePainRelief #ArthritisPainRelief #chronicpainrelief

https://www.facebook.com/watch/?v=1124676815379216

__________________________________________________________________

NANS Advocacy Results in HCSC Adding Closed-Loop Spinal Cord Stimulation to Coverage!!

https://www.neuromodulation.org/news/closed-loop-04172023

_______________________________________________________________

ActiPatch®
@ActiPatch
Get the sleep you deserve with relief from ActiPatch! ActiPatch doesn't just put a band-aid on pain. It dives deep with its Pulsed Shortwave Therapy & takes on pain at its root for sustained relief! Order at
http://actipatch.com FREE SHIPPING. #painmanagement #painfreesleep

https://twitter.com/ActiPatch/status/1737209416749887575?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1737209416749887575%7Ctwgr%5E811275876d36002daf58d004f9820350cd7adb08%7Ctwcon%5Es1_&ref_url=https%3A%2F%2Finvestorshub.advfn.com%2Fboards%2Fread_msg.aspx%3Fmessage_id%3D173613351

___________________________________________________________

Chronic Pain, Fibromyalgia and Plantar Fasciitis Help --- ACTIPATCH!!!

https://www.facebook.com/groups/1795257327156301/?multi_permalinks=7709195185762456

_____________________________________________________________
ActiPatch SA
If tennis injuries are following you off the court, ActiPatch® can help lessen your downtime by serving up clinically proven joint and muscle pain relief!²,³
🎾 Drug free¹
🎾 Can be worn 24/7, even during physical activity and sweating¹
https://www.facebook.com/share/v/jdHfKoc7x7dB...tid=CYgPv5

SAI has Registered with FDA to Sell ActiPatch in USA and Canada for 2024

Establishment Registration and Device Listing:

Establishment Name ....................... Reg number ..Current Reg Yr

AIRWAY SURGICAL APPL .CANADA 9611956 ...........2024

Nonthermal Shortwave Therapy Device Indicated For Over The Counter Use For The Treatment Of Pain / Repackager/Relabeler


SURGICAL APPL INDUSTRIES , INC. USA 1511629 2024

Nonthermal Shortwave Therapy Device Indicated For Over The Counter Use For The Treatment Of Pain
Repackager/Relabeler

KT Health, LLC ......................... UT/USA 3007282994 2024

Nonthermal Shortwave Therapy Device Indicated For Over The Counter Use For The Treatment Of Pain


(Airway Surgical is SAI's Canadian branch)

_________________________________________________________

PEMF Alzheimer’s Treatment Pilot Underway at Hackensack University Medical Center

https://www.hackensackmeridianhealth.org/en/info/geriatrics/evoke-trial

----------------------------------------------------------------------------------------

BioElectronics Corporation’s Post
View organization page for BioElectronics Corporation
BioElectronics Corporation
3,331 followers

Both NSAID therapy and neuromodulation therapy using PSWT resulted in statistically and clinically important reductions in pain level and improvement in functionality associated with cervical osteoarthritis, when used for 4 weeks. However, the PSWT intervention demonstrated superior improvements in all outcome measures when compared to the etoricoxib therapy arm, including patient satisfaction rating and decreased use of rescue pain medication. These results suggest that neuromodulation using PSWT may be a superior pain treatment option, when compared to COX-2 NSAIDS for neck osteoarthritis, and as well, represents a non-invasive, non-pharmacologic treatment option.

Product samples are available to licensed medical care providers in the USA. Request via email - info[ @newbie00

https://www.linkedin.com/posts/bioelectronics-corporation_pulsed-shortwave-therapy-in-cervical-osteoarthritis-activity-7138985310968795136-SRFJ

https://link.springer.com/article/10.1007/s42399-020-00652-y

---------------------------------------------------------------------------------------------------

New product added
https://actipatch.com/buy-1

BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

-------------------------------------------------------------------------------------------------

Top5-USA.co
Top 5 Actipatch In The US

https://www.top5-usa.com/actipatch

------------------------------------------------------------------------------------------------------

RecoveryRX
BOSTON ORTHOPEDIC & RESPIRATORY EQUIPMENT, LLC.

https://www.bostonorthoresp.com/214-4_p_10155.html?referrer=rss

BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

-----------------------------------------------------------------------------------------------------------

This is just a few FACTS to help with INTELLIGENT DD and to INVEST in BIEL, which, i/we agree with this post worth a reasonable investment:
(https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172266874;; )

" RecoveryRx repairs and regenerates damaged cells by reducing pain and inflammation and accelerating blood flow. Whereas, TENS is only blocking pain signals and has no healing effect. The major difference between the two is that a TENS unit is a short term solution that “turns off” the pain signal but CANNOT perform the function of repairing damaged tissue like RecoveryRx. "
https://www.linkedin.com/posts/lauren-jarman-380a801a9_clinicallyproven-fdacleared-noninvasive-activity-7051200138563735553-Q9Zs

7 anti-aging benefits of PEMF therapy
https://www.outlookindia.com/business-spotlight/anti-aging-benefits-of-pemf-therapy-news-259187;;

"Literally, there are so many benefits to a regular PEMF therapy session. Research by NASA and other bodies has found that PEMF therapy can deliver the following results:
Better circulation
Pain reduction
Improved muscle relaxation and performance
Decreased inflammation and swelling
Improved oxygenation in tissue
Enhanced cellular repair and recovery
Improved immune system
Better sleep "

https://higherdose.com/blogs/news/8-benefits-of-pemf-therapy?psafe_param=1&tw_source=google&tw_adid=634407957086&tw_campaign=18892036948&gad=1&gclid=CjwKCAjw44mlBhAQEiwAqP3eVqY1HlussPIpcLNFP0O10gqhWUrMI0VdqtspfI3FlKHqC0HkjB_OkBoCc08QAvD_BwE

BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

-------------------------------------------------------------------------------------------

Watch till the end!
https://www.instagram.com/reel/Cvq8j0bILP4/?igshid=MzRlODBiNWFlZA==

BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

-------------------------------------------------------------------------------------

INTRODUCING
RecoveryRx Veterinary
Drug-Free Pain Relief Device
For Indoor and Outdoor Pets
https://rrxvet.carrd.co/
BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

PEMF Ring is Saving a 14 Year Old Labrador
https://therapyproducts.net/pemf-ring-is-saving-a-14-year-old-labrador/

----------------------------------------------------------------------------------------------------------

Once, pay ATTENTION Everyone -- NOT if, IMO, NHL, NFL, NBA, WBA, MLB, PGA, Lacrosse, etc...... adopts Actipatch as a must protocol, after all those HITS, CHECKS, TRIPS, LIGAMENT PULLS/RIPS, etc.......Possibilities are ENDLESS !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

---------------------------------------------------------------------------------------------

ATTENTION all the Respected, Smart, Intelligent Investors !!!!!!! Do your OWN, INTELLIGENT, THOROUGH DD, without ANY influence from KNOWN PAID BASHERS / LIARS / MANIPULAYOTS / MISINFORMERS !!!!!!!!! Make sure, if you decide to invest ( and to decide you MUST !! ) :

#1 -- Don't put all the money you are willing to invest in one basket ( buy only one stock ), be diverse......VERY IMPORTANT -- Do your OWN, INTELLIGENT DD !!!!!!!!!!!!!!!!

#2 -- If you decide/willing to buy BIEL shares, know, that this is a HIGH RETURN / HIGH LOSS RISK ratio, but the MIRACLE PRODUCT ( ACTIPATCH ) is the key !!!!

#3 -- if you decide/willing to buy BIEL shares, invest only as much as you are willing to loose, without being hurt, FINANCIALLY !!!!!!!!!!!!!!!!!

Good luck to all !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

BIEL $$$$$$$$$$$$$$$$$$$$$$$$$
👍️0
gimmee greenbacks gimmee greenbacks 4 days ago
“But Dr. Reddy’s would be a perfect fit in my opinion.”

No doubt Hawk..Dr. Reddys is worth 4.7 BILLION DOLLARS and has a workforce of over 24,000 people, a few hundred mill would be a drop in the bucket for them.


https://en.m.wikipedia.org/wiki/Dr._Reddy's_Laboratories

Maybe it helps that Biel has some SouthEast Asian contacts?

Fun to speculate anyhow..



BIEL
👍️ 1 🥳 1
Hawk05 Hawk05 4 days ago
OrthoAlliance lead me to look at Dr. Reddy’s based on some other info.

Does it mean anything? Not sure.

But Dr. Reddy’s would be a perfect fit in my opinion.

👍️ 1

Your Recent History

Delayed Upgrade Clock